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INTRODUCTION
All organisms operate through activating and repressing genes in a coordinated
and timely manner between biological conditions. No gene or protein can work
in isolation. Understanding how interactions are formed and activated at specific
time points or conditions is a central part of understanding how specific cells work.
With the increase of high-throughput methods it is possible to obtain large
amount of data to study a cellular system from complementary aspects more eas-
ily. The vast quantity of data produced also enables data re-use and provokes new
methods for integration of heterogeneous data.
Despite all the research performed and data produced, only about one third of
human genes have been annotated to biological pathways. Hence, for the majority
of genes, interactions and their activation conditions have yet to be identified.
Production of induced pluripotent stem cells has lead to the importance of
understanding transcription factors and signalling molecules that are capable of
determining cellular states. In order to direct stem cells into desired differentiation
paths, the underlying regulatory networks have to be identified. Computational
methods can help to identify new regulators for such networks, and cell behaviour
in different conditions can be estimated using in silico modelling.
In the first part of the thesis, I provide a short overview of high-throughput data
origin and analysing methods used for identifying relationships between genes. I
also cover ways of representing the large amount of interaction data.
In the research section of the thesis, I demonstrate how different types of high-
throughput datasets can be exploited to find new connections between genes. First,
we investigated the potential of data re-usability by measuring the strength of co-
expression for extracting functionally related genes using known biological path-
ways. Next, I introduce an integration of an enrichment and clustering method.
This method enables automatic identification of gene sets that are not only co-
expressed but also share known functional annotations.
I also demonstrate utility of data integration by combining evolutionary se-
quence conservation data together with in silico predictions of regulatory binding
events. Additionally, we investigated embryonic stem cell regulation by adding
value to experimental results with in silico regulatory motif detection methods.
We refined richness of public data by making embryonic stem cell specific per-
turbation and DNA-binding data available for public use in a concise manner. I
conclude the thesis by demonstrating how data integration and filtering methods
followed by in silico modelling helps to prioritise a list of novel candidate genes
for embryonic stem cell regulation.
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CHAPTER 1
REVIEW OF LITERATURE
1.1 Measuring gene activity
Genes encoded in the DNA define how to produce RNA and proteins. However,
the amount and timing of RNA production and protein coding is affected by many
factors. In order to describe how an organism functions we study its gene activity
levels.
1.1.1 Experimental analysis
Gene activity is studied by measuring mRNA levels in the cell as only transcribed
genes can produce proteins and there are no high-throughput protein expression
methods available. Extracted mRNA from the cell has to be reverse-transcribed
to complementary DNA (cDNA). cDNA, unlike mRNA, is stable. Also, signal
amplification using PCR works only on DNA.
Low-throughput analysis
The most sensitive way of measuring gene activity is by low-throughput quan-
titative real-time primer chain reaction (Q-RT-PCR) (Gibson, Heid, & Williams,
1996). There are two quantification methods – relative and absolute. The widely
used relative quantification method amplifies the complementary DNA (cDNA),
generated by reverse transcription of mRNA, and measures the difference in ex-
pression levels compared to reference genes (Bustin, 2002). Usually, housekeep-
ing genes are considered as reference genes, as their expression should be stable
throughout different experimental conditions (Vandesompele et al., 2002). As the
expression values from Q-RT-PCR are relative to the reference genes, it makes
different Q-RT-PCR results comparable. Absolute quantification allows to mea-
sure the absolute amount of a specific mRNA sequence in a sample.
The Q-RT-PCR method however is very time-consuming and cannot be exe-
cuted in a high-throughput manner. Thus, methods that allow to measure activity
of a large number of genes simultaneously, like microarrays and RNA-seq, are
used to obtain a general overview of gene activity in biological conditions.
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High-throughput analysis
Microarrays are glass or silica slides to which tens of thousands of different short
oligonucleotides, called probes, are attached to (Lockhart et al., 1996; Schena
et al., 1995). The oligonucleotides are designed to bind with unique regions in
the transcriptome and are complementary to the cDNA sequences derived from
mRNAs. In each spot on the slide there are millions of copies of the same short
oligonucleotide sequence.
There are two main types of widely used microarrays divided by the number
of samples studied simultaneously – two-channel and single-channel chips.
In two-channel microarrays, two samples are, after labelling with different flu-
orophores (e.g. Cy3 and Cy5), mixed and hybridised to the same chip. The ratio
between the intensities of the fluorescence are used in further analysis. Alter-
natively, in single-channel microarrays (e.g. Illumina Bead-arrays, Affymetrix
GeneChip), only one fluorophore (usually Cy3 or biotin) is used. The fluorophore
labels emit light when excited by laser at certain wavelengths (usually read for
Cy3 from 532 to 570nm and for Cy5 from 635 to 670nm). The intensity of the
signal reflects the quantity of the respective transcript in the original sample and
is represented with a real number in the resulting data matrix.
The limitation of microarrays lies in the fact that one can only measure mRNAs
that have a complementary probe defined and spotted to the slide. It may be
complicated to design unique probes for all the alternative transcripts of the genes,
distinguish pseudogenes from protein coding genes and, thus, the specificity of the
readings can be below the expected accuracy and coverage level (Draghici et al.,
2006; Johnson et al., 2005). Also, microarrays have problems with background
noise and the dynamic range of detection is limited (Wang et al., 2006).
In order to overcome such limitations, RNA sequencing (RNA-seq) is used
(Wang, Gerstein, & Snyder, 2009). The RNA-seq method in principle is not lim-
ited to predefined complementary probe sets but allows to theoretically measure
all the messenger RNA in the cells. Compared to microarrays, it also has a higher
dynamic range for the quantification of gene expression levels and for distinguish-
ing alternative and rare transcripts (Marioni et al., 2008). However, microarrays
still detect low-expressed genes better, as most RNA-seq measurement power is
spent on the top 7% of the known transcriptome (Łabaj et al., 2011). Also, cur-
rent sequencing methods are still error-prone and sequence read lengths are often
not long enough (Metzker, 2010). Thus, there are often no matches to the known
transcriptome due to sequencing errors or multiple matches in the known tran-
scriptome when reads are not long enough to be matched uniquely (Trapnell &
Salzberg, 2009).
The limitation of both microarrays and RNA-seq is that these methods measure
average cell population. As the concentration of mRNA from a single cell is too
low and even when a cell population is used, the signal has to be amplified (Levsky
& Singer, 2003).
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Significant results obtained from high-throughput approaches are then vali-
dated mostly using the low-throughput Q-RT-PCR method. Q-RT-PCR and alter-
native gene expression validation methods are further reviewed in Chuaqui et al.
(2002).
1.1.2 Computational analysis
Outcome of both microarray and RNA-seq experiments is typically a numerical
data matrix where rows describe probe sets, transcripts or genes, and columns
represent the samples. This data matrix is the starting point for the following
computational analysis.
Data preprocessing
The first step in the analysis workflow is quality control (Zhang, Szustakowski, &
Schinke, 2009). The aim of quality control is to check if all samples are suitable
for further analysis.
Dye distribution needs to be examined when analysing microarrays in order
to validate that the signal is distributed equally across the array and there are
no blobs, smears or thumb prints on the chip, as these produce artefacts in the
gene activity values (Reimers & Weinstein, 2005). If original scanner files are
not available, then the images can be reproduced based on the data matrix for
easier artefact identification by human eye. Microarray samples where obvious
signal distribution artefacts are detected should be removed from the downstream
analysis.
Other quality control steps involve checking correlation values between bio-
logical and technical replicates if available (Wilkes, Laux, & Foy, 2007). The
latter should produce high correlation coefficients and explain the technical vari-
ation in the experiment.
Usually three biological replicates are used when detecting differences be-
tween two conditions which is less than the suggested minimum of 5 replicates
(reviewed in Allison et al. (2006)). Ideally, all the samples are analysed in the
same manner and at the same time. However, this is often impossible due to sam-
ple collection capabilities or technical limitations. In these cases, a batch effect
might originate from the set-up of the experiments. For example, differences be-
tween the experiments conducted on different dates, the person conducting the
experiments, the origin of the samples, and other factors need to be taken into
account when performing downstream analysis. Batch removal algorithms such
as Combat (Johnson, Li, & Rabinovic, 2007) might be needed to remove the ex-
perimental set-up factor and to measure the true biological differences between
conditions (batch removal algorithms are reviewed in Chen et al. (2011)).
The next step in the analysis workflow is normalisation. Normalisation aims at
making data from different samples or analyses more comparable to each other by
eliminating systematic biases or artefacts. Most common methods for expression
data normalisation are quantile and model based normalisation (Figure 1).
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In quantile normalisation, the empirical distributions of gene expressions are
made to be the same across every array in the experiment (Bolstad et al., 2003).
The most widely used methods for microarrays that apply quantile normalisation,
are the robust multi-array average (RMA) algorithm (Irizarry et al., 2003) and
FARMS (Hochreiter, Clevert, & Obermayer, 2006). For RNA-seq, further devel-
opments have been proposed, such as conditional quantile normalisation (Hansen,
Irizarry, & Zhijin, 2012).
Sometimes in microarray analysis, probe sets that have detection p-values
above the threshold (e.g. set to 0.05), are removed. The aim of this filtering
step is to remove probes that are not expressed in any of the arrays. Each probe
set on the array has its own detection p-value that explains the probability that
the gene measured by this probe set is actually expressed. It is calculated using
the signal intensity of the perfect match and mismatch probes in a probe set for
Affymetrix, and the background signal from negative probes for Illumina arrays.
Removal of non-expressed probes from further analysis improves the power for
detecting differentially expressed genes.
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Figure 1: Illustration of expression value and correlation changes of two biological repli-
cates during standard bioinformatics analysis steps. Both the x-axis and the y-axis rep-
resent expression values. The left plot shows that sample 1 has higher raw values than
sample 2 for respective probes (the Pearson correlation coefficient 0.9242). The middle
plot shows that after normalisation this bias is reduced (the Pearson correlation coeffi-
cient 0.9503). On the right plot, after log transformation, the overall correlation is high
but some probes have higher values in replicate 2 compared to replicate 1 (the Pearson
correlation coefficient 0.9643).
Expression matrix values representing the intensities from image analysis usu-
ally vary from zero to several thousands. In order to describe better the magnitude
of expression changes, expression values are log transformed, usually on base 2
(log2) (Figure 1) (Cui, Kerr, & Churchill, 2003; Irizarry et al., 2003).
Given the expression matrix, two major questions can be answered – which
genes are differentially expressed between conditions and which genes are co-
expressed across the conditions.
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Differentially expressed genes
Differential gene expression analysis is used to identify genes that are signifi-
cantly changed between different samples. Most common methods are the t-test,
linear models (Smyth, 2004) and rank products (Breitling et al., 2004). In addi-
tion, fold change (FC) is calculated between the mean expression values from the
biological replicates under investigation and can be used to filter out genes with
the greatest changes between conditions. As discussed before, usually the expres-
sion matrix is log2 transformed and log fold change values are used to express
changes in expression levels. Commonly a combination of thresholds to define
significantly changed genes is used, e.g. the following thresholds are applied: 2
or 1.5 fold change (log 2 is 1 or 0.585) and 0.05 for multiple testing corrected
p-value (Patterson et al., 2006; Raouf et al., 2008).
After applying FC and statistical significance thresholds, we get lists of up-
and down-regulated genes. These lists can be studied further using previously col-
lected information compendia by applying functional characterisation approaches
(described below). Log fold change values or significance p-values can also be
used for prioritising genes in the gene set.
Some of the functional characterisation tools are capable of taking the order
of the gene list into account while finding the most significant annotation terms
(Reimand, Arak, & Vilo, 2011). This is beneficial when genes with the highest
fold change belong to small and specific functional groups that would be diluted
while querying within a larger gene set (e.g. the top five genes out of a hundred
differentially expressed genes belong to endodermal cell fate specification with
the total size of nine genes).
Two genes are co-expressed when their expression profiles are correlated, mean-
ing that if one gene’s expression levels go up then the same happens with the other
gene. Co-expression can be measured with several distance measures (e.g. Pear-
son, Euclidean and Spearman’s rank correlation coefficients). The Pearson corre-
lation coefficient is among the top two most widely used correlation measures for
gene expression studies (Piasecka, Robinson-Rechavi, & Bergmann, 2012).
The Pearson correlation coefficient uses real expression values and expresses
linear dependence between the variables. For the Pearson correlation coefficient,
data is expected to have normal distribution. The Pearson correlation coefficient
can be viewed as a measure of similarity between the shape of two expression
profiles. When the directionality of expression change is the same, the correlation
coefficient is positive, and in case of the opposite expression patterns, the coeffi-
cient is negative. The disadvantage of the Pearson correlation coefficient is that it
is affected by outliers (Langfelder & Horvath, 2012). This problem is reduced if
log-transformation is applied first. The Absolute Pearson correlation coefficient
is the absolute value of the Pearson correlation coefficient and it expresses only
the change of values but not directionality.
In comparison, for the Spearman’s rank correlation coefficient, real expres-
sion values are converted to ranks by first sorting them. The Spearman’s rank
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correlation coefficient expresses the squared differences of ranks. Rank corre-
lations, such as the Spearman’s rank correlation coefficient, are less sensitive to
non-normal distribution.
Co-expressed gene pairs are often used as input for finding potentially func-
tionally related gene sets. The "guilt by association" paradigm states that if genes
behave similarly in at least one biological condition then they are potentially car-
rying out similar biological functions (Wolfe, Kohane, & Butte, 2005). This
paradigm is used widely in different functional enrichment tools where a gene
without a known function is linked to the annotations of the other genes in the
gene set.
1.1.3 Clustering genes
When analysing large biological data matrices using clustering methods, the goal
is to identify genes that behave similarly and could be co-regulated in similar
biological conditions, or share common functions.
Clustering is a method that groups data points based on the distances be-
tween the points. For example, genes are clustered together by similarities of
their expression values. Usually the correlation coefficients between the individ-
ual genes are calculated and coefficients are converted to distance metrics (e.g
the Pearson’s distance = 1 - the Pearson correlation coefficient).
Hierarchical clustering
In hierarchical clustering clusters are obtained based on the distance between val-
ues where the two points with the smallest distance are put into one cluster. Then
the next closest pair is found until all the points are clustered. This is known as
full agglomerative hierarchical clustering. Another option is divisive clustering
where, starting from one cluster containing all the observations, the sets are split
recursively. Full hierarchical clustering has a quadratic complexity which makes
this approach too slow for large datasets that need to be analysed fast.
Another alternative is to optimise the number of computations needed and use
a set of pivot points in the data. This allows to limit the number of computations
in an order of magnitude. For example, the approximate hierarchical clustering
algorithm HappieClust (Kull & Vilo, 2008) for an average size microarray ma-
trix requires only 2-3% of the calculations that are needed for full agglomerative
hierarchical clustering to produce comparable results (Kull & Vilo, 2008).
In order to obtain individual gene clusters, the full hierarchical clustering tree
needs to be cut at a certain distance. The cutting distance is usually arbitrarily
selected, and has to be chosen by the user. Visualising the clustering results with
dendrograms (described below) might help to choose the optimal cluster cutting
threshold.
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K-means clustering
An alternative way is to pre-define a number of clusters so that all the genes will
be covered. For example, if we have only two conditions, we can expect to see
three major clusters of genes (genes that go up, genes that go down and genes
that do not change significantly). In this case we can set k, denoting the number
of clusters, to 3. However, there are always genes that have expression profiles
somewhere between the expected clusters. Because of that, we get a lot of noise
in the clusters unless we are capable of pre-defining the optimal k.
The rule of thumb would set k ≈
√
n
2
which for an average of 50000 probe
sets would be close to 160. The suitability of a given k, however, depends a
lot on the studied biological conditions. Additionally, there are other methods
like the Elbow method where the number of clusters is chosen at the point where
the percentage of variance stops adding extra information (Tibshirani, Walther, &
Hastie, 2001). For a given matrix, the Elbow method helps to find the optimal
k which is dependent on the specific dataset, and needs to be calculated again
for the next experiment. The clustering outcome is also dependent on the initial
cluster centres, and can vary when using different initiation points on the same
data matrix.
1.1.4 Visualising expression data
Large numerical data matrices contain information about the measured genes but
for comprehensible presentation of similarities between data points, additional
steps need to be taken. Although programmatically it is easy to pick genes by
specific behaviour or similarity measure, different visualisation approaches help
to get a more comprehensive overview of the data for a larger audience. The
most popular approaches to visualising gene expression data are dendrograms,
heat maps, line plots and scatterplots (Gehlenborg et al., 2010).
As discussed earlier, clusters identify genes that behave similarly. In addition
to having gene lists for each cluster, it is beneficial to represent relationships be-
tween clusters. Therefore, clusters are often visualised by dendrograms – trees
of clusters linked to each other by hierarchical clustering. For each dendrogram
the distance measure is represented on the y-axis and nodes are described on the
x-axis.
Heat maps are graphical representation of data where numerical matrix values
are visualised as coloured rectangles. Usually a gradient from one colour to an-
other through a mid point (e.g. blue to white to yellow or green to black to red) is
used to demonstrate the levels of expression (e.g. red for highly expressed genes,
green for lowly expressed genes). The intensity of colour in each matrix cell in
the heat map corresponds often to the mRNA expression level of a given gene in
a specific tissue or treatment.
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Blocks of cells that have similar colours represent genes and conditions where
expression values are similar. It is easy to distinguish such coloured blocks from
each other by human eye and make a fast decision about the outcome of the ex-
periment.
Heat maps and dendrograms can also be combined. In this case expression val-
ues of individual genes or cluster averages can be represented by heat maps while
the relationships between genes (or clusters) and conditions can be described by
attached dendrograms. Original visualisation approaches by (Eisen et al., 1998)
have been developed further, for example, in the pheatmap R package developed
by Raivo Kolde.
Gene expression profiles are also often represented as line plots where the x-
axis contains conditions and the y-axis denotes expression levels. A coloured line
then represents expression changes across conditions.
High-throughput methods create very large datasets with tens of thousands of
rows and hundreds of columns. These data matrices are easily manageable by
computers but very hard to grasp by human brains if kept numerical. In order to
understand the patterns and trends in the data, usually the dimensionality of the
huge matrices needs to be reduced and visualisation methods applied (Slonim,
2002).
When analysing biological data, the main questions are often about determin-
ing sets of similarly behaving genes and pointing out significant differences be-
tween experimental conditions. Various standard analysis and visualisation steps
are applied to large data matrices, such as clustering, principal component analy-
sis, dendrograms and heat maps (Gehlenborg et al., 2010).
Principal component analysis (PCA) is used for reducing the dimensionality of
large datasets and finding the variables (contributing factors) that separate samples
the most. The principal components represent the directions where data points are
most spread out and are themselves linear combinations of the original variables.
An eigenvector is a direction in the data with the largest variance, and the
eigenvalue explains the variance of the data in that direction. The eigenvector
with the highest eigenvalue is the first principal component. The eigenvector with
the next highest eigenvalue is the second principal component and so on.
Each principal component is described by contributing factors and their load-
ings that explain the magnitude of the contribution for a specific component. The
loadings can be used to explain for example the gene’s contribution to the compo-
nents and represented in a biplot. On the plot, the genes with the largest weights
extend towards the respective component directions (Landgrebe, Wurst, & Welzl,
2002). The usage of PCA for gene expression analysis is further explained in
(Ringnér, 2008).
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Functional characterisation
Given a list of co-expressed genes, the next natural question is to find the potential
functionality the gene set could carry out and characterise the genes without a
known function.
Knowledge about genes and proteins is gathered to large structured databases.
These databases can hold either specific information (e.g. human protein-protein
interactions) or describe broader terms and relationships. The Gene Ontology
(GO) (Ashburner et al., 2000) is a bioinformatics initiative that gathers informa-
tion about genes and gene products across all species. Terms used in GO are
species-neutral. Each gene is described with terms from a controlled vocabulary.
The vocabulary is composed of three main domains: molecular function (MF)
describing activities at the molecular level; biological process (BP) describing
operations or molecular events with a defined beginning and end; and cellular
component (CC) describing cellular and extracellular parts.
The Gene Ontology is described with a directed acyclic graph where each term
has defined relationships to one or more terms inside the domain (in rare occasions
to other domains). All the genes associated with a term also belong to the parent
term (e.g. stem cell differentiation (GO:0048863) is a child term of cell differen-
tiation (GO:0030154)).
Gene Ontology annotations are widely used to search for overrepresented terms
among co-expressed gene groups. There exists a variety of software applications
that enable the users to search for enriched GO annotations for the provided gene
lists (Bauer, Gagneur, & Robinson, 2010; Huang et al., 2007; Reimand, Arak, &
Vilo, 2011).
Functional characterisation is not limited to finding overrepresented GO anno-
tations, but can be applied to any collection of previous knowledge or even to pre-
dicted data. For example, g:Profiler uses TRANSFAC (Matys et al., 2006) regula-
tory motif enrichment information; miRNA target prediction data from miRBase
(Griffiths-Jones et al., 2006); KEGG (Kanehisa et al., 2014) and REACTOME
(Croft et al., 2014) pathways; protein complexes from CORUM (Ruepp et al.,
2010); and Human Phenotype Ontology (Köhler et al., 2014) (Reimand, Arak, &
Vilo, 2011).
1.1.5 Evaluating experiments
Every time an experiment is set up, a pair of hypotheses (H0, H1) is formed to
be tested. The aim of any statistical test is to limit detecting the effect that is
not present, or missing the effect that actually is present in the data. Typically,
H0 states that there is no difference between two conditions and the alternative
hypothesis H1 states that there is a difference. A type I error describes the situation
when a true null hypothesis is incorrectly rejected (false positive) while a type II
error describes the situation when a test fails to reject a false null hypothesis (false
negative).
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In expression analysis, the main task is to look for genes that are significantly
changed between the conditions. In this case, a comparison of two groups can
be done using the t-test that assumes that the sample sizes are equal and variance
among the samples is same in both case and control groups.
When more than two groups are compared at the same time, it is beneficial
to use analysis of variance (ANOVA) statistical models (Cui, Kerr, & Churchill,
2003). With ANOVA one can test whether or not the means of several groups are
equal while controlling type I errors so the error rate threshold remains at 5%.
Multiple testing correction
With high-throughput data produced to study different conditions, and the avail-
ability of large annotation datasets, multiple testing problems come into focus
(Dudoit, Shaffer, & Boldrick, 2003). When we test the same group of genes
against different annotation groups, we have to take into account the total number
of tests we perform in order to limit the false positive results. The most com-
mon ways to adjust significance thresholds are Bonferroni correction and false
discovery rate (Benjamini & Yekutieli, 2001).
Bonferroni correction is the most conservative method to control the proba-
bility of making one or more false discoveries among all the hypotheses (family-
wise error rate). When a test involves multiple comparisons the comparison-wise
error has to be corrected by the number of comparisons done, so that the test
experiment-wise error would be at an expected level. For example, when per-
forming 50 pair-wise comparisons the Bonferroni corrected threshold for each
individual pair-wise test (comparison-wise error) should be 0.05/50=0.001 so the
experiment wise error would be 0.05.
False discovery rate (FDR) is one of the most common multiple testing ap-
proaches used in high-throughput biology. FDR controls the proportion of type I
errors made among all significant results (Benjamini & Hochberg, 2000). FDR is
less conservative than Bonferroni correction and leads to loss of fewer true posi-
tive results than Bonferroni correction.
For n alternative hypothesesH1, ..,Hn tested, p-values P1, ..Pn are calculated.
FDR ranks the p-values in increasing order and, for a given significance threshold
α, finds the largest k that satisfies
P (k) ≥ k
n
· α .
All alternative hypothesis H(1), ...,H(k) are then accepted as significant.
1.2 Gene functions
Section 1.1 of measuring gene activity was represented in a simplified manner
assuming that there are linear steps from gene to mRNA to protein levels. In
a real biological system, these steps are not linear as there are many levels that
control the amount protein present in a cell. With our current understandings and
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technological abilities, the final level of protein activities has to be approximated
using data from mRNA experiments.
In the context of this thesis we concentrate on subsets of genes that are capable
of regulating the expression of other genes or mediate the signal in stem cells and
during differentiation.
1.2.1 Embryonic stem cells
Embryonic stem cells (ESCs) are pluripotent cells that are capable of differen-
tiating to any cell type in the organism. The first human embryonic stem cells
(hESCs) were derived from the inner cell mass of a blastocyst in 1998 by Thom-
son et al. (1998). Human embryonic stem cells are the basis of three primary germ
layers: ectoderm, endoderm and mesoderm. These layers develop further to more
than 200 different cell types in the human body (Figure 2).
Blastocyst
Embryonic stem cells
Inner cell mass
Ectoderm MesodermEndoderm
Figure 2: Pluripotent embryonic stem cells are derived from the inner cell mass of a
blastocyst. These cells are capable of differentiation first to three primary germ layers
(ectoderm, endoderm, mesoderm) and finally to over 200 distinct cell types in the human
body.
The pluripotent stem cells at each cell division give birth to another pluripotent
stem cell and to one cell that starts to differentiate towards one of the three main
germ layers. This self-renewal property keeps stem cells in an undifferentiated
state.
Human embryonic stem cells are kept in the pluripotent state by expressing
three transcription factors – OCT4, SOX2 and NANOG (Boyer et al., 2005).
These three transcription factors regulate each other and a variety of target genes
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(Boyer et al., 2005; Macarthur, Ma’ayan, & Lemischka, 2009). In order to start
differentiation, the activity of these three genes needs to be decreased and the
activity of the differentiation driver genes has to increase (Yeo & Ng, 2013).
Exit from pluripotency state can be achieved by knocking down the core regu-
lators of OCT4, SOX2 and NANOG (Greber, Lehrach, & Adjaye, 2007; Matin et
al., 2004). Alternatively, overexpressing cell type specific genes individually or in
combinations leads also towards differentiation, e.g. overexpression of HEX for
hepatoblasts (Inamura et al., 2011); APP for neural differentiation (Freude et al.,
2011); GATA4 and TBX5 for cardiac specification (Dixon et al., 2011).
The commonly used term pluripotency covers at least two sub-states - naïve
and primed. The naïve or ground state describes embryonic stem cells that have no
differentiation bias. These cells are capable of forming blastocyst chimeras when
additional cells are added to preimplantation embryos; have two active X chromo-
somes (if female karyotype); express Rex1, NrOb1 and FGF4 markers. Primed
pluripotent embryonic stem cells, however, cannot form blastocyst chimeras any
more, they have an inactivated chromosome X and also have a differentiation bias.
(Nichols & Smith, 2009)
According to these properties, mouse embryonic stem cells are considered to
be in the naïve state, while the majority of human embryonic stem cells repre-
sent the latter, primed, state. However, it is possible for hESCs to adopt the naïve
phenotype, at least for limited number of passages (Hanna et al., 2010). Also,
primed mouse embryonic stem cells resembling hESCs can be produced when
isolated from the post-implantation epiblast (Tesar et al., 2007). The differences
between mESCs and hESCs, attributed for a long time to species differences, may
be due to differences of cell states, instead. It has been shown recently that when
human embryonic stem cells are treated with 5i/L/A (MEK inhibitor, GSK3 in-
hibitor, ROCK inhibitor, BRAF inhibitor, SRC inhibitor, Activin, hLIF in N2B27
medium) then primed hESCs are converted to the naïve state (Theunissen et al.,
2014).
Although the mechanisms of cell state transition from naïve to primed are not
clear yet, it can be expected to take place through gradual changes of the activity
levels of key factors. For example, it has been shown that an alternative OCT4
enhancer is used only in naïve ESCs and it is inactivated in primed state (Theunis-
sen et al., 2014). Also, gradual changes can be encoded in proteins changing their
dimerisation partners and, thus, the regulated genes. For example, OCT4 changes
its known dimerisation partner SOX2 to SOX17 during the first differentiation
steps (Kallas et al., 2014).
Alternative cellular systems used for studying gene regulation in pluripotent
stem cells are embryonic carcinoma cells. These cells are derived from germ
cell tumours, like the testicular tumour. Embryonic carcinoma cells share cell
characteristics with hESCs, and core regulatory proteins are the same as in hESCs
(Clark, 2007). Embryonic carcinoma cell lines are easier to culture and were
available as a model system for studying pluripotency before the first hESC lines
were established (Andrews et al., 2005). Embryonic carcinoma cell lines like
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NCCIT and NTERA2 have been used for studying self-renewal and pluripotency
regulatory networks (Andrews et al., 2005; Greber, Lehrach, & Adjaye, 2007;
Josephson et al., 2007).
1.2.2 Adipocytes
Adipocytes are cells of mesenchymal origin and their main function is storing
energy as fat. Mesenchymal stem cells originate from the mesoderm and differ-
entiate into bone, muscle, connective tissue and adipocytes. There are three main
types of adipose tissue – brown, brite (beige) and white (Giralt & Villarroya, 2013;
Harms & Seale, 2013).
White
adipocyte
Brite
adipocyte
Brown
adipocyte
Myocyte
White
pre-adipocyte
Mesenchymal stem cell
differentiation towards adipocytes
Myogenic
precursors
Figure 3: Differentiation of adipocyte lineages from mesenchymal stem cells. White and
brite adipocytes are differentiated from white pre-adipocytes while brown adipocytes, like
monocytes, are derived from myogenic precursors.
During adipocyte differentiation from the mesenchymal stem cells, first pre-
cursory cells are formed. These cells cannot differentiate any more towards alter-
native lineages such as muscle or bone. In the final step, terminal differentiation
into mature and functional adipocytes takes place (Figure 3).
Mouse embryonic stem cells can be differentiated directly into adipocytes
when treated with retinoic acid (Dani et al., 1997). Also PPARγ is a key reg-
ulator of adipocyte development (Rosen et al., 1999) and is capable of converting
non-adipose cells to adipocyte-like cells together with C/EBPα (Wu et al., 1999).
Although some regulators that drive differentiation of adipocytes are known, the
detail regulatory steps and participating genes are still poorly described.
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1.3 Gene regulation
Measuring gene activities across conditions and various time periods provides
us with a set of snapshots of cell populations. Based on the data of active and
inactive genes, the goal is to identify regulatory mechanisms and switches that
define when and how much certain genes are activated. Below we address mainly
the transcriptional regulation of genes.
1.3.1 Transcription factors
Transcription factors are proteins that control transcription rates of other genes
by binding to the regulatory regions. These regions are mainly promoters located
in the proximity of the gene transcription start sites (TSS) or enhancer regions
further away from the TSS. Transcription factors work as single proteins, form
homodimers or heterodimers with other transcription factors. Some transcrip-
tion factors are broadly expressed and bind to a large set of genes (e.g. TBX1,
CLOCK), while others are more specific (e.g. ZBTB32 with testis specific ex-
pression) (Vaquerizas et al., 2009). There are approximately 1500 transcription
factors in humans that can be grouped into 347 protein domains and families (Va-
querizas et al., 2009).
Chromatin immunoprecipitation
The most common high-throughput method for identifying potential transcription
factor binding sites across the genome is chromatin immunoprecipitation (ChIP).
First, the transcription factor is cross-linked with DNA, cells are lysed, for exam-
ple, with sonification, and TF-DNA complexes are pulled down using a transcrip-
tion factor specific antibody. After TF-DNA complex cross-linking is reversed
by heating, the DNA strands are purified and amplified, and identified by vari-
ous methods. Usually, the resulting DNA sequences have a length of up to 1000
base pairs. A technical overview has been provided by Nelson, Denisenko, &
Bomsztyk (2006).
Previously, sequence identification was done using specialised promoter tiling
arrays where short overlapping oligonucleotides complementary to promoter re-
gions were present (ChIP-chip method). The DNA sequences bound by the tran-
scription factor were identified by a fluorescent signal like in microarray analysis.
Alternatively paired-end-tag libraries are used where unique regions from the
genome are attached with short unique sequences for further identification (ChIP-
PET method).
Lately, the most common method is to sequence the DNA regions pulled down
in the immunoprecipitation step (ChIP-seq method). The advantage of ChIP-seq
is better coverage of the sequences, as it is not limited to pre-defined promoter
sequences. However, if the sequences are short, mapping them uniquely back to
the genome can be difficult. Longer methodology review can be found in (Ho et
al., 2011).
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Figure 4: Chromatin immunoprecipitation followed by high-throughput readout leads to
a set of DNA sequences. When aligning these we can define a peak region and map that
to the promoter of gene x. The real transcription factor binding to DNA usually happens
under the highest peak region (red). Often transcription factors work as dimers and bind
together to DNA (TF1, TF2). From this example we can extract the following relation-
ships – protein-protein interaction between TF1 and TF2 and transcriptional regulation of
gene x by both TF1 and TF2 (dashed rectangle).
Whichever method was used to identify the sequences bound by the transcrip-
tion factor, the following analysis step is peak detection (Figure 4). Most of the
transcription factors bind to short DNA regions, but from the ChIP experiments we
obtain regions that are several hundred base pairs long. The sequences are cut at
random positions around the area where the transcription factor is bound to DNA
(Nelson, Denisenko, & Bomsztyk, 2006). Therefore, by aligning the sequences,
the overlap between sequences should identify transcription factor binding sites.
There are several alternative algorithms for peak detection that are reviewed
by Barrett, Cho, & Palsson (2011).
Transcription factor binding sites
After the peak regions are identified, usually transcription factor binding sites
are searched to confirm the binding. Transcription factors recognise short, (4-12
base pairs), DNA motifs called transcription factor binding sites and bind only to
the corresponding site either alone or in complex. Each transcription factor can
recognise usually more than one unique motif.
The set of transcription factor binding sites is usually represented as a con-
sensus motif (Table 1) with alternative options at some positions, position count
matrices (Table 2) and position weight matrices (PWM) (Table 3) where each nu-
cleotide and position has some weight. Ideally, the sequence score described by a
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PWM should represent the binding energy for the sequence (Stormo, 2000). Po-
sition weight matrices are often represented with sequence logos to illustrate the
tolerance of substitutions at every position (Figure 5) (Schneider et al., 1986).
M1 C T T G C A A A T G
M2 A A T G C A A A T A
M3 A A T G C A A A T G
M4 T A T G C A A A T A
M5 A C T G C A A A T A
. . .
Mn−1 A A T G C A T A T A
Mn C A T G C A G A T C
Consensus W A T G C A A A T R
Table 1: List of n=1582 potential OCT4 binding sites. A consensus base is found for
each position and represented under the line. IUPAC nucleotide code W stands for A or
T, R stands for A or G.
A 465 1228 0 0 0 1582 1364 1582 243 472
C 356 158 0 0 1492 0 0 0 40 210
G 261 8 0 1582 90 0 97 0 241 548
T 500 188 1582 0 0 0 121 0 1058 352
Table 2: Count matrix of the OCT4 binding sites listed in Table 1.
The count matrix is obtained by first aligning the initial list of binding sites. At
each position across a set of sequences, all possible nucleotides are summed up.
In the resulting matrix, sums of columns have to be equal.
Finally, to represent the binding energy, the position count matrix is converted
to a weight matrix according to
Mk,j = log(Mk,j/bk)
where b is a background model describing the expected frequency of individual
nucleotides in the dataset (for the example in Table 3 G and C had frequency of
0.2, A and T 0.3) (Stormo, 2000).
A 0.083 0.099 −0.038 −0.038 −0.038 0.103 0.101 0.103 0.072 0.083
C 0.085 0.072 −0.038 −0.038 0.109 −0.038 −0.038 −0.038 0.049 0.076
G 0.080 0.023 −0.038 0.110 0.062 −0.038 0.064 −0.038 0.079 0.092
T 0.084 0.068 0.103 −0.038 −0.038 −0.038 0.061 −0.038 0.096 0.078
Table 3: Position weight matrix of the OCT4 binding sites listed in Table 1.
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Figure 5: Sequence logo of OCT4 binding sites based on 1582 motifs from Table 1.
The height of each letter describes information content that represents the tolerance for
substitutions in that position (Schneider et al., 1986).
A matrix of binding sites is often represented with a sequence logo (Figure 5).
The height of each letter in the logo describes information content that represents
the tolerance for substitutions in that position (Schneider et al., 1986). Positions
with a low tolerance for substitutions have high information content and are rep-
resented with larger letters. Positions illustrated with smaller letters represent
positions with low information content and high tolerance for substitutions.
Transcription factor binding data is collected to databases like TRANSFAC
(Matys et al., 2006) and JASPAR (Sandelin et al., 2004). These databases keep
both individual experimentally validated binding sites and position weight matri-
ces built on these sequences. It is common to use third party tools like STORM
(Smith et al., 2006) and STAMP (Mahony & Benos, 2007) for matching the posi-
tion weight matrices obtained from those two databases to promoter sequences.
1.3.2 Cell perturbations
Another way to study the effect of a gene for cell behaviour is to perturb its ex-
pression. Positive perturbations are usually done by over-expressing a gene by in-
troducing corresponding cDNA to the cells. Negative perturbations are performed
by knocking down mRNA expression by introducing complementary interfering
RNA (RNAi) to the cells (Figure 6). The short regulatory RNA binds to already
transcribed mRNAs and inhibits the gene activity by initiating double RNA de-
grading mechanisms.
Perturbation experiments are widely used to obtain regulatory edges for gene
regulatory networks (Ideker, Thorsson, & Karp, 2000; Molinelli et al., 2013; Pe-
terson et al., 2012; Wagner, 2002). Using only perturbation data does not allow to
distinguish if the regulatory relationship is direct or indirect between the perturbed
gene and its target genes. But combining the data with chromatin immunoprecip-
itation (Kubosaki et al., 2010) or proteomics (Sopko et al., 2014) data could help
to differentiate these two groups.
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(RNAi for TF1)
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Figure 6: In perturbation experiments, such as negative perturbation of transcription fac-
tor TF1, genes regulated by TF1 would change their expression. Genes with high ex-
pression levels (yellow) are down-regulated (blue) and vice versa. From perturbation
experiments we can conclude both negative (TF inhibits G1) and positive (TF1 activates
G2) regulatory edges (in the dashed rectangle).
1.4 Biological networks and pathways
Networks and pathways can be considered or modelled as graphs describing con-
nections between biological entities carrying out some functions in a specific bio-
logical setting.
1.4.1 Networks
Knowledge about relationships between genes are represented with networks. The
networks can be built manually by annotating each edge with experimental evi-
dence and literature data. Alternatively, biological networks are constructed using
high-throughput data such as mRNA expression, yeast two-hybrid experiments or
chromatin immunoprecipitation. In addition, automatically mined literature co-
mentions in abstracts or DNA conservation is used.
Functional relationships between genes are usually described for a pair of
genes or proteins. Each such relation can have a different experimental origin,
confidence value and direction. In order to handle such pairs in a more compre-
hensive way, the pairs are linked together forming a network. In such networks,
genes or proteins are represented by nodes, and relationships between them are
represented by edges.
Edges can either be directed or undirected. Undirected edges describe connec-
tions between two genes or proteins where only the association is known but not
its directionality. Such edges could be co-mentions or protein-protein interactions.
In gene regulation networks, directed edges explain the direction of regulation
between the nodes. For example, a node representing a transcription factor will
have an outgoing edge to the target gene. The same edge will be an incoming edge
for the same target gene (Figure 7). A node with only incoming edges is a target
node or leaf. Sometimes edges are also weighted to represent the trustworthiness
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of the given interaction. The edge weight could illustrate, for example, correlation
in a co-expression network, peak score from an immunoprecipitation study or co-
mentions in a literature network.
TF1 TF2
Gene x
G1G2
Figure 7: Minimalistic regulatory network. When TF1 is active all other genes will be
active (yellow) except G1 that is in an inactive (blue) state (in network modelling, inhi-
bition is considered stronger than activation, therefore G1 stays inactive in this example).
TF1 forms a feed-forward loop through G2 to G1 and can itself be considered a hub. TF1
and TF2 have undirected interaction that could represent protein-protein interaction or
literature co-mentioning, for example. TF2 is an autoregulative transcription factor.
The directed edges in the network can be either positive or negative. While the
majority of directed edges represent positive regulation (e.g. transcription factor
up-regulating a target gene), there are also negative regulation events that describe
inhibitory relations between the objects. For example, a repressor protein binding
to a promoter element and, thus, blocking transcription. Alternatively, genes that
show over-expression after negative perturbation of a gene will have a negative
regulatory edge from the perturbed gene.
Each biological network of representative size includes the most common net-
work motifs – connected components, hubs, cliques, feed-forward and feed-back
loops (Figure 8) (Alon, 2007). Transcription factors are usually hubs, having out-
going edges to many other genes while incoming edges from few other nodes.
Cliques are sets of nodes that are all connected to each other. Protein complexes
where each gene or protein has interactions with many other complex partners,
usually form cliques in networks. Also, tight regulatory subunits where transcrip-
tion factors regulate their own regulators such as OCT4, SOX2 and NANOG core
network in embryonic stem cells, form a clique (Boyer et al., 2005).
In a biological organism, functions are often coded in at least two alternative
ways to ensure robustness of the signal, as the systems must be robust against
genetic and environmental perturbations to be evolvable (Kitano, 2004). For a
system to have periodic behaviour, at least one negative feed-back loop is needed,
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while for the existence of multiple steady states, at least one positive feed-back
loop is needed (Gouzé, 1998; Snoussi, 1998).
Feed-forward loop Feed-back loop
Hub
Autoregulation
Clique
Figure 8: Network motifs: autoregulation – when a gene is a transcription factor and reg-
ulates itself; clique – transcription factors that have cross-regulation (like OCT4, SOX2,
NANOG); hub – transcription factor regulating many other genes; feed-forward loop –
e.g. two transcription factors regulating a common target gene (right circle) while one
transcription factor (left circle) regulates the other (middle circle) as well; feed-back loop
– e.g transcription factor (left circle) regulating a transcription factor (middle circle) and
being regulated by its own indirect target (right circle).
The most common network motif is the feed-forward loop that is composed of
a transcription factor TF1 that regulates a gene G2, and both TF1 and G2 regulate
gene G1 while TF1 regulates G1 directly as well (Figure 7) (Mangan & Alon,
2003). The OCT4, SOX2 and NANOG triplet form both self-regulatory and feed-
forward loops in hESCs regulatory networks (Boyer et al., 2005).
The feed-forward loop enables different regulatory behaviour based on the
type of regulatory edges. For example, when both regulatory edges are positive,
the feed-forward loop creates stable activation levels that are rather insensitive to
temporary changes of the input (Mangan, Zaslaver, & Alon, 2003). When the
edges are of opposite type (one positive, one negative) then the loop provides a
switch that creates a delayed oscillating response by inactivating the initial regula-
tor (Mangan & Alon, 2003; Mangan, Zaslaver, & Alon, 2003). A network without
various types of feed-back loops will only reach a unique fixed state regardless of
the initial conditions (Pigolotti, Krishna, & Jensen, 2007).
Although regulatory networks of embryonic stem cells have been composed
for years (Boyer et al., 2005; Kim et al., 2008; Wang, Levasseur, & Orkin, 2008),
there is still a lack of knowledge about what the full network of pluripotency
regulation looks like. It is known so far that there is a core triplet of transcrip-
tion factors, OCT4, SOX2 and NANOG, that regulate themselves and many other
genes to keep the hESCs in pluripotent state (Boyer et al., 2005). Also, it has
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been recently shown that ERK signalling plays an important role in keeping the
pluripotency (Göke et al., 2013). Alternatively to gene expression data, ENCODE
DNAse I footprinting and ChIP data has been used to come up with an alternative
ES regulatory network (Neph et al., 2012).
1.4.2 Pathways
Pathways characterise certain biological processes that are described as series of
reactions and interactions, and are often represented as graphs. Unlike in net-
works, where edges are often undirected, in pathways edges mostly represent
reactions and have direction. Reactions are usually operated by enzymes and
represent conversion of one substance to another.
While regulatory networks are commonly derived from high-throughput ex-
periments or through literature mining, pathways are described one reaction at
a time by human curators. Annotating certain biological functions is, therefore,
time consuming. Of course, some information can be extracted using computa-
tional approaches but the value lies behind the trustfulness of nodes and edges in
the pathway.
Biological pathways are collected and stored to major databases from where
they can be queried and visualised further. Reactome (Milacic et al., 2012) is a
hand-curated database that covers various diseases, metabolic and signalling path-
ways (Figure 9). All the information is curated and externally reviewed. Latest
version 51 covers 7760 human genes and 1428 small molecules that are organised
into 1597 pathways annotated by 17939 literature references (Croft et al., 2014).
By using orthologous proteins the information can be projected to other model
organisms.
The KEGG pathway database also collects manually curated knowledge and
automatically maps knowledge from one organism to another when there is enough
support from orthology mapping (Kanehisa et al., 2014). The current KEGG
database covers 470 pathway maps for 3660 organisms supported by 356 006 lit-
erature references (March 2015).
Although accurate, manual data curation is time-consuming and, thus, there
exists a need for automatic approaches. Pathways can be constructed using litera-
ture mining. For example, mining the vast amount of published scientific literature
helps to point out genes that are mentioned together (Wu, Schwartz, & Nenadic,
2013). More advanced methods, like natural language processing approaches, can
also detect relation types between proteins and small molecules or diseases, for
example (Yuryev et al., 2006).
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Figure 9: Reactome pathway number 263856 of Transcriptional regulation of pluripotent
stem cells. Light blue rounded rectangles represent complexes, light green rounded rect-
angles represent proteins. Edges represent various reaction types. Double pink lines mark
the membrane (nuclear and cell membrane). Figure adapted from www.reactome.org
(Croft et al., 2014)
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1.4.3 In silico modelling
Collecting data into networks helps to get a visual overview of the relationships
between genes, identify network modules and determine core genes. However,
networks are static as they only describe interactions but not their potential acti-
vation states across time or conditions.
In silico modelling helps to further study biological functions described by
networks. With modelling, it is possible to find all activity states, called steady
states, that the given network is capable of describing. These steady states can
represent, for example, different stages of cell differentiation, disease states or
cell cycle phases.
Modelling can also be used to test network conformity with the biological
functions it should describe. For example, if a network should describe differenti-
ation towards specific cell lineages, but only some of the final states are reachable
from the network by simulations, then probably some regulatory edges are miss-
ing from or are incorrect in the current network.
There are several network modelling approaches, each with different data needs
and outcomes. Roughly, the modelling methods can be separated into qualitative
and quantitative modelling.
Qualitative modelling is less stringent data-wise and a network with undirected
edges is sufficient for such a modelling approach. Qualitative modelling is also
referred to as Boolean modelling due to the binary logic of ON and OFF states
of each node. At any given time point, each node can either be active or inactive,
thus ON or OFF. With qualitative modelling, we can measure the movement of
a signal through the network, study network activation states that are stable and
need perturbations to get out of the state – steady states.
Steady states represent stable cell types or differentiation stages where cells
will stay if there is no external stimulus. For example, in embryonic stem cells we
can distinguish two steady states. One is the pluripotency state where the cells can
differentiate to any cell type and where certain key transcription factors, such as
OCT4, SOX2 and NANOG, are active. The other is an early differentiation state
towards exiting pluripotency where these factors are inactive and differentiation
markers are active. In order to transition from one steady state to the other, key
regulators need to be affected.
Qualitative modelling is widely used for regulatory networks where the link
between genes or proteins might be known, but not necessarily the size of the
effect, nor even if the regulation is direct or indirect. Qualitative modelling is
also applicable to larger networks. Networks suitable for qualitative modelling
are easier to compose from high-throughput data, unlike quantitative modelling
approaches that need quantitative data with high quality (Schlitt & Brazma, 2007).
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Quantitative modelling is more data-demanding and is usually used for smaller
networks. For example, ordinary differential equation models need many kinetic
parameters which limits the network, as it is difficult to produce such data in large
amounts. Thus, this type of modelling is less used for larger gene regulatory
networks established from noisy high-throughput data.
1.5 Combining heterogeneous data
Each individual interaction measurement method allows to dissect only one part
of the regulatory complexity of cells. The datasets become more valuable if they
can be combined to tackle the complex regulatory mechanisms active in specific
cell types and conditions. For example, when studying a transcription factor’s
direct targets in a specific cell type, perturbation experiments can be used to get
the downstream regulated genes; DNAse I hypersensitivity sites give open chro-
matin regions of potential active promoters; chromatin immunoprecipitation ex-
periments add binding events of the transcription factor (Neph et al., 2012).
Following up with the same types of experiments in other cell types or other
organisms, the regulatory event can be confirmed either to be common with more
than one cell type or even evolutionarily conserved. The latter often means that
the functional relationship is significant for the lineage of organisms where it is
conserved (e.g. primates, mammals, vertebrates).
Reconciling results from different experimental data types is not straightfor-
ward. Experiments are analysed by various platforms, results are provided in
different formats, and genes are described with a variety of identifier types. This
leads to identifier mapping problems where namespaces do not have one-to-one
matches, platform identifier intersections are far from perfect and, thus, data loss
is inevitable.
The most widely used microarray producers, Illumina and Affymetrix, provide
mapping files where the identifiers are mapped to commonly known gene iden-
tifiers, such as Ensembl IDs. This allows us to match gene names with different
platform or database specific identifiers and, thus, combine the datasets. There are
several tools such as g:Convert (Reimand et al., 2007), Syngerizer (Berriz & Roth,
2008) or BridgeDb (van Iersel et al., 2010) that provide such mapping services.
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CHAPTER 2
AIMS OF THE PRESENT STUDY
The aim of the present thesis is to apply different methodologies and data types for
studying relationships between genes with systematic approaches. The specific
aims of the thesis are the following:
1. To study the power of gene expression usage for biological pathway recon-
struction;
2. To develop a methodology for automatic highlighting of significant gene
clusters based on their co-expression and functional similarities;
3. To identify new regulatory events of adipocyte differentiation in mouse by
combining different data sources;
4. To identify alternative regulatory modules of human embryonic stem cells;
5. To prioritise genes responsible for pluripotency using qualitative modelling;
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CHAPTER 3
RESULTS AND DISCUSSION
3.1 Power of gene expression similarities for
studying pathway relationships (Ref. I)
One of the challenges in systems biology is to understand how previously pub-
lished data can be exploited for knowledge expansion. This involves understand-
ing the possibilities of different data types and might lead to detecting limitations
as well. Large quantities of mRNA expression measurements across a variety of
conditions and tissues have been and continue to be produced and gathered into
databases like ArrayExpress (Parkinson et al., 2007) or GEO (Barrett & Edgar,
2006).
Obtaining pathway relationships from gene expression data
These large-scale publicly available gene expression data collections can be re-
used for various bioinformatic experiments to confirm or extract new knowledge.
While there are plenty of experimental datasets available, the majority of human
genes are still not annotated in any of the major pathway databases. At the time
of this study (Adler et al., 2009) there were 4220 proteins described in KEGG
database (Kanehisa & Goto, 2000) and 1804 annotated in Reactome database
(version 23, 28.01.2008)(Västrik et al., 2007). Since the publication, the numbers
have grown to 6869 proteins annotated in KEGG database (16.02.2015) (Kanehisa
et al., 2014) and 7757 in the Reactome database (version 51, 20.02.2015) (Croft
et al., 2014). Although the numbers have increased tremendously, the majority
of human proteins are still not described in any pathway. Therefore, the question
of how to exploit all the public data to expand our knowledge about the functions
and interactions among the proteins remains substantial.
In this paper we studied the predictive power of using only gene expression
data to identify members of known biological pathways. We wanted to understand
if genes belonging to a pathway are co-expressed and to what extent. In addition,
we aimed to find out if there are subsets of genes that have more similar expression
profiles and could, therefore, be co-regulated and used for further candidate gene
searches.
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We used 35 curated biological pathways from the Reactome database version
23 (Västrik et al., 2007). These pathways could be further divided to signalling
pathways, metabolic processes and large protein complexes. The gene expression
dataset that we used was kindly provided to us by Margus Lukk from the European
Bioinformatics Institute in pre-publication state (Lukk et al., 2010). This expres-
sion compendium covers 6108 manually curated and quality controlled samples
across 369 different human cell and tissue types, cell lines and disease states all
measured on the AffyMetrix HG_U133A microarray platform. The expression
data was already normalised using the RMA algorithm (Irizarry et al., 2003) and
covered 22283 probe sets that converted to 12579 Ensembl gene identifiers at the
time of the analysis.
Limitations of gene expression data
Our first aim was to study the predictive power of gene co-expression to derive
members of known pathways had we not known them in advance. For this, we per-
formed a leave-one-out computational experiment where we excluded one gene at
a time from the pathway under study. For the remaining pathway members we
calculated correlations with all the remaining probe sets available in the large data
compendium. The resulting correlation values were converted to ranks with the
highest correlation being ranked 1 and the lowest correlation being the total num-
ber of correlations calculated. In this study we used two main distance measures
for calculating the correlation scores. First, we started with the Pearson corre-
lation coefficient that is widely used for gene expression similarity analysis as it
represents the relationship between two numerical vectors (in our case expression
values for two probe sets at a time). The Pearson correlation coefficient shows
the relatedness and strength of such a relationship. After initial analysis we also
performed the same steps with the Absolute Pearson correlation coefficient that
takes into account the absolute correlation and not its direction. The latter is use-
ful when expecting to see correlations between genes that have opposite effects,
e.g. suppressor-target gene pairs.
Many genes present on the HG_U133A platform have more than one probe
set. In this analysis we always picked the most favourable probe set for each gene
to maximise the correlation score for any given gene pair.
After calculating all the individual correlation scores between pathway genes
and other genes on the platform, we converted these to rank values. Finally, we
calculated the average rank across the entire pathway. If genes among the pathway
were strongly co-expressed, we would get a small rank for the genes removed
during the leave-one-out experiments. However, this was not true for the majority
of the pathways under study. The highest proportion of pathway genes, 6%, that
were ranked as first in the leave-one-out experiments were from the Translation
pathway.
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When looking at the top ten genes, the results are improved with up to 43% of
pathway genes having rank 10 or less when using the Pearson correlation coeffi-
cient. The top 10 genes represent less than 0.1% of all the possible genes on the
platform, therefore, the results can be considered significant.
Using only a subset of pathway genes
Overall, the results were not satisfactory when using all the pathway genes. This
can be due to the fact that biological pathways describe complicated biological
processes that are carried out by many genes and are inter-related over a period
of time. Therefore, all the pathway members do not need to be expressed simul-
taneously but, rather, in a more complicated and orchestrated manner. Also, the
pathway can contain subsystems or protein complexes that carry out specific func-
tions that cannot be detected by mRNA expression alone. To benefit from this, we
decided to look for an optimal subset of pathway genes that would produce the
smallest rank possible for the pathway gene left out. In this analysis we did not
take into account any topological information about the pathways as we wanted
to test the opportunities and limitations of using only gene expression values for
pathway reconstruction.
We performed an exhaustive search using the Pearson correlation coefficient
and the Absolute Pearson correlation coefficient, and converted correlation values
to distance that varies from 0 to 1. Our aim was to find the optimal threshold that
would produce the highest average rank for each of the leave-one-out genes for a
given pathway. We considered thresholds from the set of values that varies from
0 to 1 with a step of 0.02.
This approach resulted in lower ranks for all the pathways as seen in Table 1
and Figure 1 in Paper I. For example, for the Translation pathway, the results im-
prove from 6% to 28% of pathway genes ranked 1st and from 43% to 53% of path-
way left out genes ranked in the top 10. Similar improvements were seen when
we used the Absolute Pearson correlation coefficient as a similarity measure. The
most promising results were achieved for Translation, Electron transport chain
and Pyruvate metabolism and TCA cycle pathways, while Signaling by NGF had
the worst outcomes in the leave-one-out experiments.
This can be explained due to the nature of genes that form the given pathways.
For example, the Translation pathway consists mostly of ribosomal genes that
need to be expressed simultaneously to form the large protein complex. At the
same time signalling pathways, like Signalling by NGF, probably have low ranks
for the known pathway genes due to the fact signalling pathways do not func-
tion through large protein complexes or transcriptional control but have a more
dynamic regulation where many factors are still to be discovered. Such path-
ways often utilise post-translational modifications and short-living ligand-receptor
bindings that carry out the pathway functions (Fortini, 2009).
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Potential new candidate genes
There were many genes from the platform that did not belong to a given pathway
but produced smaller similarity ranks to the pathway than the known left out path-
way genes. We considered as potentially interesting candidates all genes that had
an average rank up to 100 when using a subset of pathway genes and the Absolute
Pearson correlation coefficient. Using Gene Ontology (Ashburner et al., 2000)
information extracted from g:Profiler (Reimand et al., 2007) and protein-protein
interaction data from Intact (Kerrien et al., 2007), HPRD (Peri et al., 2003) and
ID_SERVE (Ramani et al., 2005) through GraphWeb software (Reimand et al.,
2008), we estimated how many of the candidate genes having small ranks could
actually be linked to the pathways.
For the majority of 35 pathways we had more than 100 genes (Table 2 in Paper
I) that could be either pathway members or linked to the pathway based on their
high co-expression to characterised pathway members. For some pathways, like
Cell cycle checkpoints and Cell cycle, mitotic, more than half of the candidate
genes actually had known protein-protein interactions with the pathway members.
For some other pathways, like the Electron transport chain, the known protein-
protein interactions were limited or even missing. The full results are given in
Table 2 in Paper I.
Already during the article publication process we learned that, for example, the
TNFRSF10C candidate gene that had been shown to have protein-protein inter-
actions with four Apoptosis pathway genes, was annotated in the next Reactome
version to the Apoptosis pathway.
Summary
The main outcome of our work is the detected limitation of using only gene ex-
pression data to describe pathway membership in different biological pathway
types. We also show that it makes more sense to use only a subset of strongly
correlated pathway members for such tasks. Many of the candidate genes we
found can be related to the pathways they were proposed from. Our results can
also be used as a baseline for benchmarking other, more complicated pathway
reconstruction methods.
3.2 Compact visualisation of microarray data
based on functional enrichments (Ref. II)
In the previous section we addressed the importance and widespread distribution
of microarray experiments available to the public. These datasets can be used in a
combined manner to perform systematic analysis with bioinformatics methods to
find functional connections between genes. However, it is also important to study
each individual dataset separately. This approach is needed for experimentalists
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to interpret the results, make relevant conclusions and compare the outcomes of
similarly executed experiments.
Current microarray platforms cover tens of thousands of probe sets at a time.
Even with minimalistic visualisation approaches this leads to high dimensional
heat maps or dendrogram images that are hard to fit onto a screen and grasp by
the human eye. The large images covering all the information in the data might
also present data points that are not relevant for the current experimental set-up
and, therefore, exploit much needed space in the output.
Clustering expression data
Experimentalists use microarrays mostly to find genes with similar expression
profiles across the studied conditions. Genes that behave similarly are often co-
regulated and take part in common processes. This forms the basis of guilt by as-
sociation reasoning (Wolfe, Kohane, & Butte, 2005). Therefore, clustering genes
based on their expression patterns can help in creating hypothesis about the poten-
tial molecular function or biological process that a gene without a known function
is carrying out.
The most common approach to get an overview of a large-scale expression
experiment is to perform full hierarchical clustering and then dissect the large
dendrogram into smaller clusters. This is usually done either by using some fixed
distance measure to cut the tree or by predefining the number of expected clusters
when using the K-means approach. Both of these strategies require user provided
input that is difficult to know beforehand as each dataset might have unique cluster
forming parameters that produce the best results.
Once the clusters are identified, each of the clusters is characterised using Gene
Ontology terms (Ashburner et al., 2000), common pathways or over-represented
regulatory motifs. When there are hundreds or thousands of clusters with potential
impact, this step can be exhausting for a human to analyse.
Automatically finding functionally related gene sets
To overcome the problems stated above, we came up with a web based tool that
helps to find biologically significant clusters in the microarray data. In order to do
this, we combine fast approximate hierarchical clustering, functional enrichment
analysis and the smart cluster cutting algorithm to create a compact heat map and
a dendrogram.
In large microarray datasets there are close to 50 000 probe sets that would
lead to almost 1 250 000 000 values representing all against all distances. Even
with currently available computational resources, this leads to a vast number of
computations, especially if computed for many datasets on the fly at a web server.
With the help of the HappieClust algorithm (Kull & Vilo, 2008) we are able to
reduce the computation times an order of magnitude compared the standard ap-
proaches. This is achieved by first computing a subset of pairwise distances and
then computing all pairwise distances between similarly expressed genes, as well
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as distances to a subset of more distant pivot genes chosen by random. Based on
this, HappieClust is able to approximate the full hierarchical clustering that has
been shown to produce biologically comparable results to standard agglomerative
hierarchical clustering (Kull & Vilo, 2008). These hierarchical clustering results
are then functionally characterised. For all clusters with size ranging from 5 to
1000 genes, we find all statistically significant Gene Ontology (Ashburner et al.,
2000) terms, Reactome (Västrik et al., 2007) and KEGG (Kanehisa & Goto, 2000)
pathways and regulative motifs from Transfac (Matys et al., 2006) and miRBase
(Griffiths-Jones et al., 2006) using g:Gost (Reimand et al., 2007). The overrep-
resentation significance is calculated using a hypergeometric test that is used to
assess if a function is enriched among the sample and is represented by:
Pα =
min(n,K)∑
k
(
K
k
)(
N−K
n−k
)(
N
n
)
where for a functional annotation α, the probability Pα is calculated based on k
genes from a set of n genes having annotation α when out of the N genes in the
genome, K genes have annotation α. These probabilities are then corrected for
multiple testing.
The analysed clusters are hierarchically related while differing in size, there-
fore we calculate the cluster size weighted score for each cluster. We normalise
the summarised individual hypergeometric p-values with the cluster size n and
score each cluster with score q:
q =
1
n
∑
α
(−loge(pα)) .
Compact visualisation of functional clusters
The enrichment analysis helps to identify clusters that are composed of genes that
share functions or could be regulated in similar a manner. Our aim is to highlight
clusters that are most significantly annotated in the full dendrogram.
We achieve this by first looking for clusters that have a high annotation score
q. We start from the highest scoring cluster and consider that as an enriched
cluster. At the same time we exclude all of its child and parent clusters from
further analysis and do not show these in the output.
Second, in order to minimise the output, we look for clusters that have anno-
tation scores below the significance threshold or inappropriate size. Starting from
the root of the dendrogram we pass it recursively. All the clusters that do not have
an enriched cluster as a child cluster are compressed and hidden from the final
output.
By carrying out these two steps we achieve the compression of the original
heat map of approximately 50 000 pixels in height if a one pixel row is used
per gene to few hundreds of clusters on one image with less than 5000 pixels in
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Figure 10: Overview of VisHiC output based on microarray experiment GSE2248 (mes-
enchymal precursor cells derived from embryonic stem cells) (Barberi et al., 2005) from
GEO database (Edgar, Domrachev, & Lash, 2002).
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height with the same row parameters. The size of the latter images can be fit
to the screen unlike the image that shows all the expression profiles of individual
genes. In order to make the final output carry as much information as possible, we
combine the heat map that depicts gene activation and repression profiles together
with the dendrogram that features the functional enrichments of clusters (Figure
10). We use colour-coded squares to signify enriched clusters. The size of the
square illustrates the size of the cluster. The colour of the square represents the
functional domain that had the lowest p-value for that specific cluster, e.g. red
denotes the biological process domain from GO.
Figure 11: Enriched annotation groups of VisHiC cluster 42762 based on microarray
experiment GSE2248 (mesenchymal precursor cells derived from embryonic stem cells)
(Barberi et al., 2005) from GEO database (Edgar, Domrachev, & Lash, 2002).
For each of the clusters we provide best annotations for every functional do-
main, mark functional annotations that are uniquely related to the given cluster
and provide hyperlinks for further detailed analysis in g:Profiler (Figure 11).
Summary
VisHiC is a web tool that allows to create an easily interpretable overview of ex-
pression datasets. It highlights clusters of genes that not only are expressed in the
same manner but also share functional annotations. The complicated decisions of
choosing at what distance to cut an expression dendrogram or how many clusters
to look for with the K-means algorithm, are removed from the user side. Auto-
matic functional enrichment analysis and the following cluster filtering saves time
in getting an initial overview of affected processes and helps to find gene sets to
concentrate on in the downstream investigation. VisHiC can be the second step
of every mRNA level study using microarray or next generation sequencing after
quality control and before the differential expression analysis steps. With VisHiC
one can identify sets of genes that otherwise could go unnoticed as they are not
part of the initial hypothesis.
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3.3 Integration of data layers for revealing new
regulatory processes (Ref. III, IV)
Biological objects, especially multicellular organisms can be viewed as complex
molecular machineries carrying out complicated processes. The aim of experi-
mental biologists together with bioinformaticians is to understand the processes
by measuring the system in every possible way. This leads to a large variety of
experiments for the biological system under study and, thus, creates a challenge
of how to combine all the results in a meaningful way. Usually there are major
experimental data types collected by a laboratory, e.g. microarrays for measur-
ing mRNA abundance, or chromatin immunoprecipitation followed by chip or
sequencing for identification of protein binding locations. Initially, the primary
data is analysed individually, but often this does not lead to major breakthroughs.
Instead, new questions arise that the data in hand is not able to answer. Combining
the results with other complementary experiments can reveal additional findings.
3.3.1 Adipocyte differentiation regulation
With the progress of studying a variety of different organisms, from simple bac-
teria to more complex mammals or plants, it is possible to carry over knowledge
from one organism to another. This promotes more complicated studies in the
model organism with the goal of transferring knowledge to the human. Also, the
more organisms are sequenced and studied, the greater our understanding of the
evolution and emerging functionalities becomes. General understanding is that
functional DNA regions evolve more slowly and fewer mutations are tolerated
compared to "junk" DNA. These functionally active regions, such as protein cod-
ing genes or to some extent transcription factor binding sites, are highly conserved
across species. Comparison of rodent-human sequences has been used to identify
regulatory regions in humans (Wasserman et al., 2000). In our work we use DNA
conservation as an additional layer of evidence when identifying functional tran-
scription factor binding sites in the mouse genome.
Adipocyte regulation
In this study our goal was to understand the gene regulation mechanisms active
during adipocyte development from mouse embryonic stem cells. Adipocytes
are cells derived from mesenchymal stem cells (MSCs) that form adipose tissue.
Although the general two-step process of adipogenesis, preadipocyte formation
from MSCs and terminal differentiation into mature adipocytes is known, the ex-
act regulatory events of early events of adipocyte development are not fully clear
yet.
In this study we contributed to data analysis of adipocyte differentiation. Retinoic
acid receptor β agonist CD2314 was used to stimulate mESCs differentiation
towards adipocytes. In parallel adipocyte differentiation was repressed through
addition of glycogen synthase kinase 3 (GSK3) inhibitor BIO. For comparison,
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combination of the agonist and inhibitor and control media were used. RNA was
extracted on day 3 before any compounds were added; just after stimulation on
day 6; and for effects on later differentiation stages on day 11.
Clustering genes by expression profiles
RNA levels were measured with Affymetrix GeneChip Mouse Genome 430 2.0
microarrays (available as E-TABM-668 in ArrayExpress (Rustici et al., 2013)).
Differentially expressed genes were identified using the Limma package from
Bioconductor (Smyth, 2004). Genes were clustered by their activation timings.
Five main clusters were identified:
• Cluster 1 with up-regulated genes by CD2314 on day 6;
• Cluster 2 with down-regulated genes by CD2314 on day 6;
• Cluster 3 with up-regulated genes by CD2314 on day 11;
• Cluster 4 with down-regulated genes by CD2314 on day 11;
• Cluster 5 with up-regulated genes by CD2314 on both day 6 and day 11.
Initial microarray results were confirmed by measuring gene expression us-
ing quantitative real-time PCR. Out of the 30 tested genes 29 showed compara-
ble expression patterns to microarrays. Clusters were further characterised using
g:Profiler (Reimand et al., 2007) and annotated with known protein-protein inter-
actions from the Human Protein Reference Database (Peri et al., 2003).
In Cluster 1 we found that early adipocyte differentiation is related to blood
vessel formation in mESCs; in both Cluster 1 and 5 we saw enrichment of neural
development related genes in early adipocyte development; in Cluster 1 and 3 we
observed WNT pathway genes being up-regulated during adipocyte development
(Figure 2 in paper III).
Significant regulatory motifs
In addition to identifying differentially expressed transcription factors, we looked
for overrepresented regulatory motifs of known transcription factors. We ex-
tracted 3000 bp long promoter regions for every gene using UCSC genome database
(mm8 release) (Karolchik et al., 2008). These regions consisted of 1000 bp down-
stream of the transcription start site (TSS) and 2000 bp upstream of the TSS.
Promoter regions were scanned with position weight matrices describing reg-
ulatory motifs of transcription factors. Matrices were obtained from TRANSFAC
(version 11.4) (Matys et al., 2006) and JASPAR (Sandelin et al., 2004) databases
and matched with STORM software (Smith et al., 2006).
Many of the known adipocyte development regulators from homeo box (HOX),
forkhead box (FOX family, e.g FOXC2 (Gerin et al., 2009)) and nuclear receptor
(Nr family e.g. NR2F2 (Xu et al., 2008)) gene families were found. We also saw
down-regulation of known adipogenesis inhibitors, such as MSX2. Transcription
factors expressed during adipocyte development but without a known relation to
adipogenesis were characterised using literature. Additionally, their expression
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Figure 12: Statistically over-represented TFBSs in CD2314-regulated gene promoters on
day 11. Differentially expressed TFs during mESC adipogenesis are marked with stars.
Adapted from Figure 7 in Ref. III.
data were explored for mesenchymal differentiation patterns. Majority of these
transcription factors were found to be expressed during mouse embryogenesis in
mesenchymal areas or/and in the adipose progenitor cell compartments of mouse
adipose tissue.
It is known that some of the adipocyte regulators, e.g. C/EBP are conserved
(Rosen et al., 2000) on the DNA level across species. Therefore, we incorpo-
rated DNA conservation data as an additional layer of information to understand
the adipocyte regulation. We downloaded the euarchontoglires DNA conservation
track from UCSC and used it to filter motif matches. Every transcription factor
binding site match was evaluated using a conservation threshold from the set of
thresholds that varies from 0.7, to 1.0 with a step of 0.1. The value represents
the strength of conservation where 1.0 denotes perfect conservation across the
included species. For some of the promoters, none of the thresholds led to signif-
icant results and, therefore, we also performed an analysis using no conservation
data. In this case we took the average of the best three hits in the promoter, while
in the initial analysis we only took the highest scoring hit per promoter.
We detected 16 significantly enriched motifs in Cluster 1 and 14 motifs in Clus-
ter 3 (Figure 12). Some of the transcription factors related to the enriched motifs
had been shown before to be active in adipocyte differentiation (e.g. Leukemia-
related factor (LRF) (Laudes et al., 2004) or Early growth response protein 2
(EGR2) (Chen et al., 2005)). Additionally, we found enriched motifs related to
the Activator protein 2 transcription factor family known to be expressed highly in
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neural crest cells (Mitchell et al., 1991). It has been previously shown that neural
crest cells can differentiate into adipocytes (Billon et al., 2007), therefore, we hy-
pothesised that AP-2 could regulate adipocyte generation through the neural crest
developmental pathway.
Finally, we combined expression profiles, protein-protein interaction data and
transcription factor binding site enrichment analysis. We noticed that three of
the enriched motifs on day 11 after CD2314 stimulation belong to transcription
factors up-regulated on day 6 just after the compound treatment. These are pair re-
lated homeobox 2 (PRRX2), myeloid ecotropical viral integration site 1 (MEIS1)
and cartilage homeo protein 1 (CART1) transcription factors (marked with ? on
Figure 12). We hypothesised that MEIS1 could be regulating adipocyte com-
mitment through protein complex with PBX1 and HOXB4 proteins. After Paper
III was published our co-authors showed that PBX1 is an adipocyte development
regulator that promotes adipocyte generation from neural crest cells during em-
bryogenesis (Monteiro et al., 2011).
Summary
We studied adipocyte differentiation by treating mouse embryonic stem cells with
differentiation promoting compound CD2314 and inhibitor BIO. We clustered
genes by their expression patterns. For each cluster we searched overrepresented
and evolutionarily conserved regulatory motifs. Motifs found in Cluster 3, CD2314
treatment measured on day 11, were matched to transcription factors being differ-
entially expressed already on day 6. Based on a combination of complemen-
tary data sources we proposed that three transcription factors (MEIS1, CART1,
PRRX2 ) could be new potential regulators of early adipocyte differentiation from
mouse mesenchymal stem cells.
3.3.2 Alternative regulation of human embryonic stem cells
Embryonic stem cells are pluripotent cells that are capable of differentiating into
any cell type in the organism. Human ESCs are kept in the pluripotent state by
expressing core regulators SOX2, NANOG and OCT4 (Boyer et al., 2005). Al-
though the core genes are known, the full process of keeping the pluripotency
state and even more importantly, the mechanisms controlling early differentiation
steps are still unclear. With this study our aim was to investigate the downstream
targets of OCT4.
Finding peaks in ChIP-enriched regions
We performed in the embryonic carcinoma cell line NCCIT, OCT4 chromatin
immunoprecipitation followed by hybridisation on NimbleGen two-array set of
human promoter tiling arrays. Three biological replicates of OCT4 binding to the
DNA were analysed. After quality control and quantile normalisation we had to
exclude one array out of six due to uneven dye distribution in the chip. This left
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us with 3 replicates for array 1, and 2 replicates for array 2.
We applied three independent peak finding algorithms to the normalised data
MA2C (Song et al., 2007), TAMALPAIS (Bieda et al., 2006), brute-force algo-
rithm developed in-house at Max Planck Institute (Chavez et al., 2009). A large
number of peaks were detected only by one algorithm out of three. This could be
due to the set-up of the algorithms, e.g. TAMALPAIS assumes less than 5% of
the probes are actual binding sites. It has also been shown previously that there is
a larger variation in results between the algorithms applied on the same array than
same algorithm applied on different array platforms (Johnson et al., 2008).
Results obtained from each of the three algorithms were considered equal.
Regions identified by one algorithm in three replicates creates an equal score to
a peak identified by three separate programs. If a region was identified in all the
replicates by all three programs then we gave it the peak score 1.0. If only one
program identified a peak in two replicates out of three then the score was 0.222.
With this approach we found 497 genes with peak scores of at least 0.5.
For experimental validation, we randomly picked 4 peaks that were identified
by all three programs, and 2 peaks identified uniquely by each of the programs,
10 regions in total. All ten peak regions were successfully validated by real-time
PCR (Figure 2D in Paper IV).
When we compared the identified target genes with similar experiments done
with another embryonic carcinoma cell line NTERA2 (Goto et al., 1999) and
embryonic stem cell line H9 (Boyer et al., 2005), we found an overlap of 31
genes (including core regulators OCT4, SOX2 and NANOG). When comparing
with only the H9 data, the overlap was 46 genes.
Regulatory modules of OCT4 target genes
OCT4 is known to bind to the ATGCAAAT consensus sequence (Chew et al.,
2005; Loh et al., 2006). In all peak regions we searched for motifs with Leven-
shtein distance up to two from the consensus sequence. We aligned the matching
sequences and created a new position weight matrix out of this set of sequences
(Figure 4C in Paper IV).
We defined a PWM threshold score for downstream analysis by taking the
median motif score from peaks with score 0.5 or above. The resulting PWM
matching threshold 7.3 was used for downstream motif analysis. OCT4 is known
to form a heterodimer with SOX2 (Remenyi et al., 2003; Williams, Cai, & Clore,
2004). Hence, we did the same analysis with the SOX2 transcription factor and
the SOX2 consensus sequence CATTGTT (Chambers & Smith, 2004; Pesce &
Scholer, 2001).
We identified 372 target genes that had both the OCT4 and SOX2 motif with
a score above the threshold. We got an overlap of 293 genes when comparing to
332 OCT4 and SOX2 target genes from (Boyer et al., 2005).
We identified 6 distinct potential modules of OCT4 transcriptional regulation
by its binding to DNA (Figure 13). The first module covers 39 genes that have
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both SOX2 and OCT4 motifs in the peak regions. From this group we validated
OCT4 binding in the NANOG promoter with a band shift assay. The second
module consists of 122 genes that had OCT4 motif but no SOX2 motif in the
peak regions. We validated OCT4 binding to an evolutionary conserved region
in USP44 promoter. The third module covers 65 promoters with only the SOX2
motif and no strong OCT4 motif.
USP44 — Oct4 motif only SPIC — PORE motif
TGIF2 — Sox2 motif only DHDDS — MORE motif
36330000 36330500 36331000 36331500
Positions on chr15
88267500 88268500 88269500
Positions on chr12
Positions on chr12
26628500 26629000 26629500
Positions on chr20 Positions on chr1
94468500 94469000 94469500 94470000
Positions on chr12
Replicate 1
Replicate 2
Replicate 3
Tamalpais
MAC2
Brute-force
Replicate 1
Replicate 2
Replicate 3
Tamalpais
MAC2
Brute-force
Replicate 1
Replicate 2
Replicate 3
Tamalpais
MAC2
Brute-force
Replicate 1
Replicate 2
Replicate 3
Tamalpais
MAC2
Brute-force
Replicate 1
Replicate 2
Replicate 3
Tamalpais
MAC2
Brute-force
Replicate 1
Replicate 2
Replicate 3
Tamalpais
MAC2
Brute-force
SPRED1 — Oct4 and Sox2 motifs DUSP — Neither Oct4 nor Sox2 motif
100391500 100392000 100392500 100393000
34633000 34633500 34634000 34634500
Figure 13: Six distinct OCT4 transcriptional regulation modules. DNA positions il-
lustrated in x-axis. y-axis represents peak score defined by overlap of individual peak
regions. Peaks were identified by TAMALPAIS (continuous line), MAC2 (dashed line)
and the brute force algorithm (dotted line). Colours of the line represent replicates (red –
replicate 1, blue – replicate 2, green – replicate 3).
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For more than half of the peak regions we were not able to find neither the
OCT4 nor the SOX2 motif. These promoters of 271 genes might be targeted
by OCT4 binding together with unknown protein-protein interaction partners that
bind to DNA; OCT4 might bind in some unknown configuration to DNA and thus
recognizing motif that we did not know to look for; our motif matching threshold
was too stringent to find all the true binding occurrences.
For these promoter regions we applied de novo motif discovery algorithms and
looked for overrepresented motifs. Promoter regions from the defined peaks were
analysed with the TAMO package (Gordon et al., 2005) that combines MEME
(Bailey & Elkan, 1994), MDScan (Liu, Brutlag, & Liu, 2002) and AlignACE
(Hughes et al., 2000) methods. The identified motifs were then matched against
the known transcription factor binding site data in the TRANSFAC (version 11.3)
(Matys et al., 2006) and JASPAR (version 3) (Sandelin et al., 2004) databases
using the STAMP tool (Mahony & Benos, 2007). In total we found 4 distinct
motifs that could be related to 8 potential transcription factors (Figure 10 in Paper
IV).
Previously it has also been shown that OCT4 is able to co-operatively bind
to the Palindromic Oct factor Recognition Element (PORE) ATTTGAAATG-
CAAAT by two OCT4 molecules (Botquin et al., 1998) and in a similar manner
to the MORE element (more PORE, ATGCATATGCAT) (Tomilin et al., 2000).
We were able to identify 4 genes with PORE and 10 genes with MORE element
in their peak regions.
We were also aware that our experiments might miss true positive targets of
OCT4. So we looked for genes that had a positive direct regulation in other ex-
periments, such as in (Boyer et al., 2005), but no significant binding in our data.
Out of these genes the most promising gene was GADD45G that, based on the
OCT4 motif in its promoter, would belong to module 2. We could confirm the
binding of OCT4 to the predicted motif by a band shift assay and ChIP-real-time-
PCR. GADD45G activity increases during early differentiation from ESCs, thus,
indicating that GADD45G could be involved in inducing loss of self-renewal.
Also our microarray results with over-expression of GADD45G for two days sug-
gest that increased levels of GADD45G lead to up-expression of genes belonging
to cell cycle and differentiation processes (e.g. differentiation markers EOMES,
BMP4, MSX1), while not significantly affecting the core regulatory complex of
OCT4, SOX2 and NANOG. Since the publication of Paper IV it has been shown
that GADD45G is required for early embryonic cells to exit pluripotency and enter
differentiation in Xenopus (Kaufmann & Niehrs, 2011) and its expression across
species is conserved from Xenopus to medaka fish to mouse (Kaufmann, Gierl, &
Niehrs, 2011).
Creating the Embryonic Stem Cells Database
Embryonic stem cells came into focus in 1998 when Thomson and colleagues
were able to isolate human ESCs from blastocysts (Thomson et al., 1998). Since
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then many research groups around the world have investigated these cells in a va-
riety of ways. This has led to similar and complementary experiments produced
in different labs. Data richness allows to study similarities and differences across
the experiments, makes it possible to pinpoint the uniqueness of cell lines or or-
ganisms; identify core targets of the regulators identified in different organisms
using a variety of chip types or microarray producers. In order to benefit from this
variety of data we need to collect it in one place and make it comparable.
We collected a number of experiments performed on the most widely used em-
bryonic stem cell lines for human and mouse. In addition to embryonic stem cell
lines, we also included embryonic carcinoma cell lines that are easier to maintain
but are biologically similar to the embryonic stem cells (Andrews et al., 2005;
Damjanov, Horvat, & Gibas, 1993). We searched for already published articles
studying the regulation of embryonic stem cells and looked for high-throughput
experiments in the supplementary files or in uploaded datasets in the public do-
main. We were able to collect 31 datasets from 13 different publications. For
mouse we found 9 perturbation datasets (Ivanova et al., 2006; Loh et al., 2006;
Masui et al., 2007; Sharov et al., 2008; Walker et al., 2007) and 18 TF-DNA in-
teraction datasets (Chen et al., 2008; Loh et al., 2006; Mathur et al., 2008). For
human we were able to find 7 perturbation datasets (Babaie et al., 2007; Greber,
Lehrach, & Adjaye, 2007, 2008) in addition to the GADD45G experiment pro-
duced in this study (Jung et al., 2010) and 5 public TF-DNA interaction datasets
(Boyer et al., 2005; Jin et al., 2007; Lister et al., 2009) in addition to the OCT4
immunoprecipitation experiment carried out in this study (Jung et al., 2010).
All the original datasets were checked for missing data, converted to common
format and imported to a MySQL database. The computational complexity to
merge all these experiments to one database comes from the inclusion of two or-
ganisms and use of different experimental platforms leading to different identifier
types and a varying number of present genes. In order to make the datasets com-
parable and enable searching across the datasets, we converted all the original
identifiers to Ensembl gene IDs (Ensembl version 53) using the g:Convert tool
(Reimand et al., 2007). In cases when we were not able to convert all the probe
IDs to Ensembl identifiers, only the original identifiers are kept in the database.
We used a central identifier namespace across all the experiments so we could
match different datasets and provide all the results in one table. Ensembl iden-
tifiers between mouse and human species are mapped using orthology data from
the Ensembl database through the g:Convert tool from g:Profiler (Reimand et al.,
2007).
All perturbation datasets included in the database are microarray experiments.
We used the already analysed form of the data provided by the authors. We ap-
plied the standard statistical significance threshold of 0.05 and considered genes
to be differentially expressed only if they had log2 fold change above 1.5 between
the control and perturbed conditions. In the output we illustrate gene behaviour
with coloured table cells (Figure 14). Strong green and red colours describe sig-
nificant fold changes while lighter tones show events that are significant but the
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fold change value is below the threshold we set. When no information is present
in a particular dataset for a given gene, we mark it with a gray cell. White cells
represent no detectable changes in the datasets.
Figure 14: Screenshot of the Embryonic Stem Cell Database (March 2015). Datasets
are described in columns, genes in rows. Datasets with yellow background are mouse
specific, violet for human specific datasets. Each binding event from a ChIP experiment
is marked with a 3sign. Significant expression changes for perturbation experiments are
expressed with colours (green – down-expression, red – up-expression).
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We also included chromatin immunoprecipitation studies that were done using
PET, array, or sequenced after pull-down. We did not re-analyse the data and
used only the binding events defined by the original authors. For some of the
experiments we only have binary information of the binding (for the majority of
human ChIP experiments and (Loh et al., 2006) for mouse), while for the others
we also have a binding score provided in the data (e.g. (Chen et al., 2008; Mathur
et al., 2008)). Binding events are illustrated in the web table with a 3sign. In the
datasets like (Loh et al., 2006) where there can be more than one binding event
per gene promoter, we mark the number of binding events with the corresponding
number of 3signs.
The database can be queried using a large variety of gene and protein identi-
fiers thanks to the g:Convert tool that translates almost any gene identifier types
to Ensembl gene IDs (Reimand et al., 2007). We also support queries by Gene
Ontology (Ashburner et al., 2000) annotation identifiers. This allows the user
to look for expression patterns and common regulators for genes that have been
annotated into the same biological function, cellular component or are known to
share molecular function.
We also provide an alternative view to the data through the Gene filtering view
that enables to look for specific behaviour across datasets rather than query spe-
cific genes. It allows to set binding or expression direction filters to each indi-
vidual dataset. For example, one can look for genes that are known to be down-
regulated after OCT4 is knocked down in RNAi experiment but have not been
detected in any of the OCT4 immunoprecipitation experiments. These hypo-
thetically indirectly regulated genes are great candidates for finding intermediate
transcription factors that mediate the signal from OCT4 to the downstream target
genes. Such potential transcription factors can be picked from the other columns
covering datasets that have no filters set.
Summary
In this work we analysed the OCT4 immunoprecipitation dataset in the context
of previously published results. We identified transcription factor binding events
using three distinct algorithms and treated them equally when defining the regions
bound by OCT4. We further characterised the peak regions by matching OCT4
and SOX2 motifs. This led to the definition of six distinct modules of OCT4 target
genes. For the module where neither OCT4 nor SOX2 motifs could be found, we
proposed 4 alternative motifs and potential factors that could be regulating these
genes. Finally, we gathered a compendium of publicly available data relevant
for embryonic stem cell research. We created a freely available database that
holds data from perturbation and immunoprecipitation experiments from mouse
and human embryonic stem and carcinoma cell lines. The database can be queried
in a gene oriented or a behaviour oriented manner, it promotes comparison of
datasets and provides means for new hypotheses.
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3.4 Identifying new key regulator supporting
pluripotency in human embryonic stem cells
using qualitative modelling (Ref. V)
The key regulators that keep embryonic stem cells in the pluripotent state are
known (Boyer et al., 2005). However, there still remain unanswered questions
about the active mechanisms of gene regulation that maintain the pluripotent state.
We also know little about the identity of factors capable of launching early differ-
entiation.
Expanding the known core regulatory network
In order to study the human pluripotency regulatory network further, we first gath-
ered public knowledge about the core regulatory network (Babaie et al., 2007;
Boyer et al., 2005; Jung et al., 2010; Matin et al., 2004; Xu et al., 2009). This led
to a literature network consisting of 10 genes and 32 edges.
Next, we expanded the obtained network by incorporating 7 perturbation datasets
(Babaie et al., 2007; Greber, Lehrach, & Adjaye, 2007; Jung et al., 2010) that we
had collected earlier to the Embryonic Stem Cell Database (Jung et al., 2010).
The experiments we used were done using embryonic and embryonic carcinoma
stem cell lines. The 7 perturbation experiments covered the three core regulators
of hESCs – OCT4, SOX2 and NANOG; the critical growth factor added to the
medium for keeping hESCs in the pluripotency state – FGF2; and factors respon-
sible for early differentiation – BMP4, ACTA, GADD45G.
All the perturbation experiments were performed using microarrays. Fold
change was calculated between the control and perturbed conditions. We included
only genes that had at least 1.5 log2 fold change with p-value less than 1.0e-05
and detection p-value less than 1.0e-05. Each such gene was connected to its reg-
ulator with either a positive or a negative edge. This allowed us to expand the
initial network of 10 nodes and 32 edges to a large dense hairball-like network
consisting of 16395 edges and 7862 nodes.
Filtering the large regulatory network
The resulting network of such a large size complicates any kind of in silico mod-
elling algorithms. Therefore, we had to apply different filtering approaches to
reduce the network size. Our aim was to verify the genes showing the highest
potential of being regulators of the pluripotent state. Thus, we concentrated on
genes that would be the easiest to target experimentally. We chose to keep in the
expanded network only genes that code proteins that are either located at the cell
surface (receptors) or secreted into the media (ligands). We used Gene Ontol-
ogy categories cell surface receptor linked signaling pathway (GO:0007166) and
receptor binding (GO:0005102). After this filtering step we were left with 847
genes and 7862 edges in the network.
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Figure 15: All genes that had an identical set of incoming edges were clustered together
with all their edges described in the panel below (A). Finally, new regulatory edges were
introduced creating feed-back loops from clusters to regulators (dashed red line edge from
C36 to ACTA), thus producing individual regulatory models (B). Adapted from Figure 2
in Ref. V.
The added nodes derived from the perturbation experiments results can have
1 to 7 edges connecting them back to the core network. We reasoned that genes
that are under more tight regulation, meaning they were perturbed in most of the
experiments, could play a more important role in keeping the pluripotency state
or initiating early differentiation. Thus, for further steps we kept only genes that
were significantly up- or down-regulated in at least 5 out of the 7 perturbation
experiments. This allowed us to remove 738 genes and 1471 edges from the
network.
Using only a small number of datasets leads to a network where many of the
individual genes in the network are regulated in an identical manner, and we can-
not distinguish their individual effect in the given network. Therefore, to reduce
the network size even more before starting the modelling, we clustered all the
network nodes by their incoming edges, putting into a cluster genes that had iden-
tical regulatory edges (Figure 15). This allowed us to get the final network of 69
nodes and 347 edges. All the following in silico experiments were done using the
network on (Figure 16).
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Figure 16: Hairball-like network that consists of only genes that are perturbed by at least
5 out of 7 experiments and are either receptors or ligands. Genes that had identical incom-
ing edges are clustered together (e.g C36 is a cluster of two genes). Positive regulation is
marked with red edges, negative with blue edges.
Modelling the network
The obtained network can already be used as an input for experimentalists to de-
sign validation experiments but that would lead to hundreds of experiments cost-
ing a lot of time and money. Therefore, our aim was to use in silico experiments
to single out genes with the highest potential to support pluripotency in human
embryonic stem cells.
In order to solve this problem we designed a computational approach that al-
lows us to perform in silico perturbation experiments and measure the impact of
the perturbed gene on the pluripotency state.
Edges in our network can represent either direct or indirect regulation as we are
not able to distinguish the two types while using only the perturbation results. It
was also out of the question to produce more experimental parameters that would
be needed for quantitative modelling approaches such as differential equations.
Thus, we selected qualitative (Boolean) modelling that deals with genes as binary
switches, as best suited for our network type.
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Biological networks are known to be rich in feed-back and feed-forward loops
(Macarthur, Ma’ayan, & Lemischka, 2009; Milo et al., 2002; Remy et al., 2006)
that provide the robustness to keep their biological state. Our combined network
only had the initial clique of the three core regulators and few feed-back loops
from the initial literature network. All the genes added from the perturbation
experiments had only incoming regulatory edges meaning there was no feed-back
from these genes to the core regulators.
To overcome this limitation, we artificially introduced such feed-back loops to
the core regulators from one target node at a time. Each original network with
an added edge forms a model network. We measure the impact of the introduced
edge on the pluripotency state by calculating steady states of the model network.
We performed the in silico perturbation experiments using boolSim software
(version 1.0) (Garg et al., 2009). We ran boolSim in synchronous mode where all
nodes change their activation states simultaneously in sequential time points. We
let the program do the number of calculation steps needed to obtain the steady
states. Every in silico perturbation experiment produced zero or more steady
states.
We considered steady states to be both fixed and strongly connected steady
states, where some of the network nodes were in cyclic mode. Each steady state
indicates the potential activation and inactivation status of our model network.
Each such state is described by a binary vector where 0 marks the passive and 1
the active mode of each node in the network.
Our original network had two steady states – one where the pluripotency mark-
ers (OCT4, SOX2, NANOG) where up-regulated and early differentiation markers
(BMP4, GADD45G) were down-regulated at the same time; and the second state
representing early differentiation where the activity levels were opposite to the
previous steady state.
In total we had 1180 models as we introduced both a negative and a positive
regulatory edge from each of the 59 terminal nodes to 10 core regulators. We did
in silico knock-out and over-expression for each regulatory node included in the
model (this covers 10 core regulators and a terminal node from which we created
the feed-back loop) so each model network was perturbed 22 times in total. For
further analysis we combined such binary vectors into one steady state matrix per
model network. In the matrix each column represents a node in the network, and
each row represents one steady state.
Evaluating the models
The steady state matrices were reduced by keeping only columns that corre-
sponded to the pluripotency markers OCT4, NANOG and SOX2, and early dif-
ferentiation markers GADD45G and BMP4. The resulting binary matrices were
further dissected using principal component analysis (PCA) that allows to repre-
sent complex multidimensional data as two-dimensional plots.
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Figure 17: Model scoring. Each model was scored using the sum of angles between
pluripotency markers (x-axis) and an angle between pluripotency and differentiation
markers (y-axis). Models selected for validation (marked with red) had small angles be-
tween pluripotency markers and a large angle between pluripotency and differentiation
markers. The validated model consisting of IL-11 is marked with green.
We evaluated each model using angles between eigenvectors defined by the
first two principal components of the marker genes from the PCA analysis. Each
eigenvector expresses the loadings in the first two principal components, and an-
gles between such vectors represent the correlation between activity states of two
genes. The final score for each model was based on an angle between the average
eigenvector of pluripotency markers (OCT4, SOX2, NANOG) and early differen-
tiation markers (BMP4, GADD45G). We looked for model networks that would
produce a small angle between cellular state markers (either pluripotency or dif-
ferentiation markers) and a large angle between different states. For experimental
testing we chose markers that had a minimal angle between pluripotency markers
and a maximal angle between differentiation markers and pluripotency markers
(Figure 17).
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Validation of candidate genes
We picked 15 candidate genes from the 8 top scoring models for experimental val-
idation. For only 6 genes out of the 15 recombinant proteins or known inhibitors
were available. So perturbations experiments were performed with CXCL12,
EPHB2, EPHB3, IL-11, JUN and WNT3A at different molecular concentrations.
While most of the candidate genes did not show a significant effect on the pluripo-
tency state, the Interleukin-11 (IL-11) provided promising results.
The potential of IL-11 to keep hESCs in pluripotency state was validated by
making cells grow without the standard medium containing bFGF but, instead,
with supplemented IL-11. The cells were followed for 9 passages and immuno-
histochemistry results confirmed the expression of core hESCs markers OCT4,
SOX2, NANOG and TRA1-60 (Figures 4 and 5 in Paper V).
Additional microarray experiments were carried out to compare the effect of
bFGF addition and removal with the addition of IL-11. The correlation results
of IL-11 treatment expression patterns place it between the deprived bFGF and
bFGF treatment suggesting that FGF2 and IL-11 might control the pluripotency
state through different mechanisms and with unequal strength.
IL-11 is a cytokine from the same IL-6 protein family as LIF which is neces-
sary for maintaining pluripotency in mouse ESCs. Both cytokines operate through
the same gp130 receptor (Nandurkar et al., 1996; Timmermann et al., 2000) in-
teracting with Janus kinases. LIF is known to be a key factor keeping the mouse
ESCs, that are known to be in more naïve state compared to the hESCs, in the
pluripotent state. Based on our results we can hypothesise that IL-11 might play
a role in converting the primed cells to a more naïve state, however it might need
additional factors to achieve this.
Summary
In this work we showed how in silico experiments executed in a systematic man-
ner can lead to identification of novel key regulators in a well studied biological
system. We combined literature data with high-throughput perturbation datasets
to study potential regulators of pluripotency and early differentiation in human
embryonic stem cells. With different filtering approaches, we reduced the initial
hairball-like network to a moderate size that we could model using qualitative
modelling methods. Introducing feed-back loops between target genes and regu-
lators in silico, we were able to measure the impact of such loops to the network
status. All models were evaluated using eigenvectors representing cellular state
markers. Based on the score, we chose 8 modules consisting of 15 genes. Out of
the 6 actually tested genes the most promising effect was shown by Interleukin-11
that is capable of replacing bFGF known to be critical factor in the medium for
keeping hESCs in pluripotency state.
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CONCLUSIONS
The results of this thesis can be summarised as as follows.
I. Options for using only gene expression data for finding components of
known pathways are limited.
We detected limitations of using only gene expression data to describe path-
way membership in different biological pathway types. Based on our analy-
sis, it makes more sense to use only a subset of strongly correlated pathway
members for such tasks. Even when using only co-expression data, the
novel candidate genes could be linked to the pathways they were predicted
from.
II. Combining hierarchical clustering with automatic functional enrichment
analysis helps to find co-expressed and co-functional gene sets.
Highlighting gene clusters that are both co-expressed and share functional
annotations helps to get an initial overview of affected processes. Compli-
cated clustering parameters are removed from the user and an easily inter-
pretable overview is provided.
III. Combination of DNA motifs with DNA conservation data or chromatin im-
munoprecipitation identifies new regulatory information for stem cells.
Studying adipocyte differentiation using gene expression data and motif
matching approaches we proposed that three transcription factors (MEIS1,
CART1, PRRX2) could be new potential regulators of early adipocyte dif-
ferentiation in mouse.
We defined six distinct modules of OCT4 target genes based on data from
chromatin immunoprecipitation and motif matching experiments. For genes
indirectly regulated by OCT4, we proposed 4 alternative motifs and poten-
tial factors that could be regulating these genes.
IV. Embryonic Stem Cells Database enables comparison of gene behaviour
across large data compendia.
We gathered publicly available data relevant for the embryonic stem cell
research into the Embryonic Stem Cell Database. The freely available
database holds data from perturbation and immunoprecipitation experiments
from mouse and human embryonic stem and carcinoma cell lines. The
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database allows easy comparison of datasets and provides means for creat-
ing new hypotheses.
V. Integration of high-throughput data followed by in silico modelling allows
to identify candidate genes for pluripotency regulation in human embryonic
stem cells.
We combined literature data with high-throughput perturbation datasets and
followed up with qualitative modeling. Using this approach, we identified
IL-11 – a novel key regulator for pluripotency in human embryonic stem
cells.
The main outcome of the thesis:
Integration of different high-throughput datasets enables establishing gene-
gene relationships that would not be possible when looking at a single data type
in isolation.
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SUMMARY IN ESTONIAN
Suuremahuliste andmete kasutamine geenidevaheliste seoste
leidmiseks
Elusorganismi genoomis kodeeritud geenid määravad ära millistest RNA ja val-
gu molekulidest organism koosneb. Kuid geenide teadmine ei kirjelda veel ära,
kuidas organism toimib, millal ja kuidas erinevad geenide produktid avalduvad ja
mida need teevad. Geenide omavahelised seosed ilmnevad näiteks koos avaldu-
mises, valkude vaheliste seostena, valk-DNA seostena ja erinevate bioloogiliste
radade koostoimes. Kõigi nende seoste kirjeldamine ning võimaluse korral mu-
deldamine aitab meil sügavamalt mõista bioloogilise organismi olemust. Samuti
on arvutuslike meetoditega võimalik katsetada, kas meie mudelid kirjeldavad bio-
loogilist uurimisobjekti piisavalt täpsed.
Seoses suure läbilaskevõimega tehnoloogiate odavnemisega on erinevate bio-
loogiliste protsesside mõõtmise kaudu saadavad andmemahud praegu pidevas kas-
vutrendis. Sellest tulenevalt on arvutusliku bioloogia üheks peamiseks eesmärgiks
käesoleval ajal võimalikult automaatsete vahenditega leida keerukaid geenide va-
helisi seoseid. Selleks saab ära kasutada laialdaselt levima hakanud suure andme-
mahuga eksperimentide tulemusi nagu geenikiipide abil mõõdetud geeniekspres-
siooni andmed, DNA ning RNA järjestamised ja valkude seondumised DNA-ga.
Andmemahtude tohutu kasv nõuab uusi meetodeid toorandmete analüüsiks, oma-
vaheliseks kombineerimiseks ning tulemuste visualiseerimiseks.
Käesoleva doktoritöö annab esmalt ülevaate geenide aktiivsuse mõõtmise eks-
perimentaalsetest ja arvutuslikest meetoditest ning geenihulkade funktsionaalsest
kirjeldamisest. Töös käsitletakse lähemalt embrüonaalseid- ja rasvatüvirakke ning
nende peamisi regulaatoreid. Samuti käsitletakse bioloogilisi võrgustikke, geeni-
devaheliste seoste leidmist ning enam levinud võrgu motiive. Lühidalt käsitletakse
ka bioloogilisi radasid ning nende erinevust regulatoorsetest võrgustikest. Sellele
järgneb võrgustike mudeldamise lühiülevaade. Kirjanduse ülevaate viimases osas
käsitletakse suuremahuliste ning eriilmeliste andmete integreerimiseks vajalikke
samme.
Eksperimentaalses osas on püstitatud järgmised eesmärgid:
1. analüüsida ja hinnata geeniekspressiooni andmestike kasutamise võimalusi
bioloogiliste radade kirjeldamisel,
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2. luua metoodika sarnase ekspressioonimustri ja funktsionaalsusega geeni-
de automaatseks leidmiseks ning visualiseerimiseks suurtest geeniekspres-
siooni andmestikest
3. tuvastada embrüonaalsete tüvirakkude ja rasvarakkude regulatoorseid ele-
mente kasutades erinevat tüüpi eksperimentaalsete andmete kombineerimist
4. prioritiseerida pluripotentsuse eest vastutavaid kandidaatgeene kasutades
kvalitatiivset mudeldamist
Uurimustöö peamised tulemused on järgnevad:
1. Bioloogiliste radade komponentide leidmiseks on piiratud võimalused, kui
kasutakse ainult geeniekspressiooni andmeid. Bioloogiliste radade taasloo-
misel, kasutades geeniekspressiooni andmestikke, on esmaseks piiranguks
radade tüübid. Valgukomplekside ning metaboolsete radade komponenti-
de ekspressiooni sarnasus on oluliselt suurem kui signaaliradade liikmete
vahel. Oluline on kasutada mitte kõiki raja komponente vaid tasub kesken-
duda raja alamosadele, mis sagedamini on sarnaselt reguleeritud kui raja
komponendid üldiselt. Eriti kehtib see suurte ning keeruliste signaaliradade
puhul.
2. Automaatne grupeerimis- ja visualiseerimismetoodika aitab leida funktsio-
naalselt sarnaseid geenide alamhulki suuremahulistest ekspressiooni and-
mestikest. Suuremahuliste mikrokiibi andmete esmaseks automaatseks ana-
lüüsiks saab kasutada ligikaudse hierarhilise klasterdamise ja funktsionaal-
se rikastamise kombineerimist. Sel viisil on kerge välja tuua geenide alam-
hulki, mis on sarnase ekspressiooniga ning ühiste funktsionaalsete kirjel-
dustega. Seda tüüpi visuaalne ülevaade aitab märgata huvitavaid geenigrup-
pe, mida teiste meetoditega edasi uurida.
3. Kombineerides DNA järjestuste konserveerumisinfot arvutuslike motiiviot-
simisalgoritmidega on võimalik esile tõsta rasvatüvirakkude kõige olulise-
maid transkriptsiooni regulaatoreid. Evolutsiooniliselt konserveerunud bio-
loogiliste funktsioonide uurimisel on kasulik arvesse võtta DNA konservee-
rumisinfot. Regulatoorsete motiivide kombineerimine konserveerumisinfo-
ga võimaldas leida rasvatüvirakkude differentseerumise kulgu mõjutavaid
regulaatoreid.
4. Ühendades motiiviotsingud ja regulatoorsete valkude DNA-le seondumise
info, on võimalik eristada otseseid ning kaudseid märklaudgeene. Inimese
embrüonaalsete tüvirakkude ühe keskse regulaatorvalgu OCT4 märklaud-
geene saab jagada kuude peamisse gruppi. Enamasti seondub OCT4 otse
sihtmärgile või seondub koos tuntud partneriga SOX2. Lisaks reguleerib
OCT4 sihtmärke läbi vähelevinud homodimeersete komplekside. Osad siht-
märk geenid on reguleeritud tundmatu partneri või tundmatu OCT4 motiivi
kaudu.
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5. Suuremahulistele andmetele on integreerimise ja omavahel võrreldavaks te-
gemisega võimalik anda lisaväärtust. Koondades kokku ja tehes avalikku-
sele ligipääsetavaks erinevate publikatsioonide lisafailides avaldatud info,
on võimalik leida geenide vahelisi seoseid, mida eraldiseisvaid andmeid
analüüsides ei saa teostada.
6. Andmete integreerimine ning arvutuslik mudeldamine võimaldab leida uusi
olulisi geeniregulatsiooni võrgustiku regulaatoreid. Kombineerides hästi an-
noteeritud geenidevaheliste seoste võrgustikku suuremahuliste häirituse kat-
setega, on võimalik koostada suuri geenivõrgustikke. Erinevate filtreerimis-
ja grupeerimismeetoditega on võimalik saadud võrgustikku kärpida, kes-
kendumaks hõlpsamini valideeritavatele geenidele. Mudeldamisega on või-
malik lühikese aja jooksul viia läbi arvutuslikke rakkude mõjutamise eks-
perimente, mis laboratoorsete katsete puhul nõuaks palju ajalist ja rahalist
resurssi.
Käesolevas uurimistöös on näidatud erinevaid bioinformaatilisi viise kui-
das suuremahuliste ning eritüübiliste eksperimentaalsete andmete kombi-
neerimist saab rakendada geenidevaheliste seoste leidmiseks. Töö põhiline
tulemus on, et erinevat tüüpi suuremahuliste andmestike integreerimine või-
maldab leida selliseid geenidevahelisi seoseid, mida ei oleks võimalik leida
kui analüüsiksime üht andmestikku korraga.
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